M James Barrett - Insider Trading Tracker

Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)

US ˙ NasdaqCM ˙ US00653A1079

Pengenalan

Halaman ini menyediakan analisis menyeluruh tentang sejarah dagangan orang dalam yang diketahui M James Barrett. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Adalah haram bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat khusus bukan awam. Ini tidak bermakna haram bagi mereka untuk membuat sebarang perdagangan dalam syarikat mereka sendiri. Tetapi mereka mesti melaporkan semua perdagangan kepada SEC melalui Borang 4. Walaupun terdapat sekatan ini, penyelidikan akademik menunjukkan bahawa orang dalam - secara amnya - cenderung untuk mengatasi prestasi pasaran dalam syarikat mereka sendiri.

Purata Keuntungan Perdagangan

Purata keuntungan perdagangan ialah purata pulangan semua pembelian pasaran terbuka yang dibuat oleh orang dalam dalam tempoh tiga tahun terakhir. Untuk mengira ini, kami memeriksa setiap pembelian pasaran terbuka yang tidak dirancang oleh orang dalam, tidak termasuk semua dagangan yang ditandakan sebagai sebahagian daripada pelan dagangan 10b5-1. Kami kemudian mengira prestasi purata dagangan tersebut sepanjang 3, 6 dan 12 bulan, dengan purata setiap tempoh tersebut untuk menjana metrik prestasi akhir bagi setiap dagangan. Akhir sekali, kami puratakan semua metrik prestasi untuk mengira metrik prestasi untuk orang dalam. Senarai ini hanya termasuk orang dalam yang telah membuat sekurang-kurangnya tiga dagangan dalam dua tahun lepas.

Jika keuntungan berdagang orang dalam ini ialah "N/A", maka orang dalam sama ada tidak membuat sebarang pembelian pasaran terbuka dalam tempoh tiga tahun terakhir, atau dagangan yang mereka buat adalah terlalu baru untuk mengira metrik prestasi yang boleh dipercayai.

Kekerapan Kemas Kini: Harian

Lihat senarai pedagang dalaman yang paling menguntungkan.

Lihat Orang Dalam Dengan Kedudukan Tertinggi

Syarikat dengan Kedudukan Orang Dalam yang Dilaporkan

Pemfailan SEC menunjukkan M James Barrett telah melaporkan pegangan atau perdagangan dalam syarikat berikut:

Sekuriti	Tajuk	Pegangan Terkini Dilaporkan
US:SENS / Senseonics Holdings, Inc.	Director	86,930
US:PHAS / PhaseBio Pharmaceuticals Inc	10% Owner	0
US:CLVS / Clovis Oncology Inc	Director	14,770
US:ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)	10% Owner	82,978,668
	10% Owner	40,702
US:BE / Bloom Energy Corporation	10% Owner	7,729,641
	Director, 10% Owner	15,300
US:ARDX / Ardelyx, Inc.	10% Owner	9,169,210
US:GLYC / GlycoMimetics, Inc.	Director, 10% Owner	11,000
US:MULE / Mulesoft, Inc.	10% Owner	0
US:SURF / Surface Oncology Inc	10% Owner	0
US:TCON / TRACON Pharmaceuticals, Inc.	10% Owner	707,964
US:TSRO / TESARO, Inc.	10% Owner	9,681,129
US:TNTR / Tintri, Inc.	10% Owner	0
US:RARX / Ra Pharmaceuticals, Inc.	10% Owner	5,490,073
US:APPN / Appian Corporation	10% Owner	0
US:SYBX / Synlogic, Inc.	10% Owner	4,228,940
US:SBBP / Strongbridge Biopharma plc	10% Owner	8,282,616
US:CRCM / Care.com, Inc.	10% Owner	252
US:RYTM / Rhythm Pharmaceuticals, Inc.	10% Owner	0
US:MRSN / Mersana Therapeutics, Inc.	10% Owner	0
US:ROKA / Roka Bioscience, Inc.	Director, 10% Owner	3,000
US:ZSAN / Zosano Pharma Corp	10% Owner	952,809
US:ILIU / Interleukin Genetics, Inc.	10% Owner	20,120,724
US:OPWR / Opower, Inc.	10% Owner	0
US:SUPN / Supernus Pharmaceuticals, Inc.	Director	97,355
US:TRIV / TriVascular Technologies, Inc.	10% Owner	0
US:EPZM / Epizyme Inc	10% Owner	5,854,351
US:AVTX / Avalo Therapeutics, Inc.	10% Owner	0
US:LOXO / Loxo Oncology, Inc.	Director, 10% Owner	7,812
US:VTAE / Vitae Pharmaceuticals, Inc.	10% Owner	464
US:HPTX / Hyperion Therapeutics Inc	10% Owner	0
US:CSBR / Champions Oncology, Inc.	10% Owner	37,500,000
US:BOX / Box, Inc.	10% Owner	2,091,457
US:US09739CAB81 / Boingo Wireless Bond	10% Owner	3,569,210
US:TRVN / Trevena, Inc.	10% Owner	4,811,691
US:DATA / Tableau Software, Inc.	10% Owner	1,964,192
US:CVT / Cvent Holding Corp	10% Owner	2,639
US:DERM / Journey Medical Corporation	10% Owner	0
	10% Owner	4,659,333
US:FOLD / Amicus Therapeutics, Inc.	Director, 10% Owner	15,000
	10% Owner	0
US:ECOM / ChannelAdvisor Corp	10% Owner	0
US:TRGT / Targacept	10% Owner	0
US:ADNC / Audience Inc	10% Owner	0
	10% Owner	952
US:GRPN / Groupon, Inc.	10% Owner	41,260
	Director, 10% Owner	0
US:WDAY / Workday, Inc.	10% Owner	4,642,425
US:MM /	10% Owner	8,196,614
US:FIO / Franklin Income Opportunities Fund	10% Owner	1,333
	10% Owner	15,000
US:ECHO / Echo Global Logistics Inc	10% Owner	0
US:INHX / Inhibitex, Inc.	Director, 10% Owner	0

Bagaimana Mentafsir Carta

Carta berikut menunjukkan prestasi saham sekuriti selepas setiap dagangan pasaran terbuka dan tidak dirancang yang dibuat oleh M James Barrett. Perdagangan tidak dirancang ialah dagangan yang tidak dibuat sebagai sebahagian daripada pelan dagangan 10b5-1. Prestasi saham dicatatkan sebagai perubahan peratus kumulatif dalam harga saham. Sebagai contoh, jika perdagangan orang dalam dibuat pada 1 Januari 2019, carta akan menunjukkan perubahan peratusan harian sekuriti kepada hari ini. Jika harga saham naik dari $10 kepada $15 pada masa ini, perubahan peratus terkumpul dalam harga saham ialah 50%. Perubahan dalam harga daripada $10 kepada $20 ialah 100% dan perubahan dalam harga $10 hingga $5 ialah -50%.

Secara dasarnya, kami cuba untuk menentukan sejauh mana dagangan orang dalam berkait rapat dengan pulangan berlebihan (positif atau negatif) dalam harga saham untuk melihat sama ada orang dalam menetapkan masa dagangan mereka untuk mendapat keuntungan daripada maklumat orang dalam. Pertimbangkan situasi di mana orang dalam melakukan perkara ini. Dalam keadaan ini, kami menjangkakan sama ada (a) pulangan positif selepas pembelian, atau (b) pulangan negatif selepas jualan. Dalam kes (a), carta PEMBELIAN akan menunjukkan satu siri keluk condong ke atas, menunjukkan pulangan positif selepas setiap transaksi pembelian. Dalam kes (b), carta JUALAN akan menunjukkan satu siri keluk condong ke bawah, menunjukkan pulangan negatif selepas setiap transaksi jualan.

Walau bagaimanapun, ini sahaja tidak cukup untuk membuat kesimpulan. Jika, sebagai contoh, harga saham syarikat berada dalam pendakian bukan disebabkan kitaran selama bertahun-tahun, maka kami menjangkakan semua plot selepas pembelian akan condong ke atas. Begitu juga, kemerosotan bukan disebabkan kitaran selama bertahun-tahun akan mengakibatkan plot pasca perdagangan condong ke bawah. Kedua-dua carta ini tidak akan mencadangkan aktiviti perdagangan orang dalam.

Penunjuk terkuat ialah keadaan di mana harga saham adalah sangat kitaran, dan terdapat kedua-dua isyarat positif dalam carta PEMBELIAN dan plot negatif pada carta JUALAN. Situasi ini akan sangat menunjukkan orang dalam yang menentukan masa perdagangan untuk kelebihan kewangan mereka.

Pembelian Orang Dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan	Simbol Saham	Orang dalam	Saham Dilaporkan	Harga Dilaporkan	Saham Dilaraskan	Harga Dilaraskan	Asas Kos	Hari ke Maks	Harga pada Maks	Maks Keuntungan ($)	Pulangan Maks (%)
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam APPN / Appian Corporation - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam APPN / Appian Corporation - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam ARDX / Ardelyx, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

2014-06-24 ARDX New Enterprise Associates 12, Limited Partnership 510,442 14.0000 510,442 14.0000 7,146,188 162 32.89 9,642,249 134.93

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam ARDX / Ardelyx, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

2014-12-26 ARDX BARRETT M JAMES 296 21.5449 296 21.5449 6,377 131 8.32 -3,914 -61.38

2014-12-26 ARDX BARRETT M JAMES 296 21.5449 296 21.5449 6,377

2014-12-26 ARDX BARRETT M JAMES 1,972 21.2784 1,972 21.2784 41,961

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam AVTX / Avalo Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam AVTX / Avalo Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam BE / Bloom Energy Corporation - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

2018-07-27 BE NEW ENTERPRISE ASSOCIATES 10 L P 1,333,333 15.0000 1,333,333 15.0000 19,999,995 61 35.8 27,733,326 138.67

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam BE / Bloom Energy Corporation - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam BOX / Box, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam BOX / Box, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam CSBR / Champions Oncology, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam CSBR / Champions Oncology, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam DERM / Journey Medical Corporation - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam DERM / Journey Medical Corporation - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam FOLD / Amicus Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam FOLD / Amicus Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam GRPN / Groupon, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam GRPN / Groupon, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

2013-08-15 GRPN BARRETT M JAMES 3,846 9.7700 192 195.4000 37,575 265 5.3300 -36,552 -97.28

2013-08-15 GRPN BARRETT M JAMES 27,595 9.7709 1,380 195.4180 269,628

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam MRSN / Mersana Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam MRSN / Mersana Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam RYTM / Rhythm Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam RYTM / Rhythm Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam SENS / Senseonics Holdings, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam SENS / Senseonics Holdings, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam SUPN / Supernus Pharmaceuticals, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam SUPN / Supernus Pharmaceuticals, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

2015-12-08 SUPN BARRETT M JAMES 70,913 14.7498 70,913 14.7498 1,045,953 58 10.1300 -327,603 -31.32

2015-12-07 SUPN BARRETT M JAMES 71,067 14.3835 71,067 14.3835 1,022,192

2015-12-04 SUPN BARRETT M JAMES 70,990 14.5394 70,990 14.5394 1,032,152

2015-11-25 SUPN BARRETT M JAMES 16,179 16.3480 16,179 16.3480 264,494

2015-11-18 SUPN BARRETT M JAMES 43,000 16.5010 43,000 16.5010 709,543

2015-11-17 SUPN BARRETT M JAMES 50,000 16.7092 50,000 16.7092 835,460

2015-11-16 SUPN BARRETT M JAMES 19,650 16.1341 19,650 16.1341 317,035

2015-11-13 SUPN BARRETT M JAMES 100,000 16.2561 100,000 16.2561 1,625,610

2015-06-16 SUPN BARRETT M JAMES 55,105 16.8527 55,105 16.8527 928,668

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam SYBX / Synlogic, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam SYBX / Synlogic, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam TRVN / Trevena, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

2014-12-10 TRVN New Enterprise Associates 12, Limited Partnership 1,000,000 4.0000 40,000 100.0000 4,000,000 282 332.5 9,300,000 232.50

2014-02-05 TRVN New Enterprise Associates 12, Limited Partnership 472,410 7.0000 18,896 175.0000 3,306,870

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam TRVN / Trevena, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Sejarah Dagangan Orang Dalam

Jadual ini menunjukkan senarai lengkap dagangan orang dalam yang dibuat oleh M James Barrett seperti yang didedahkan kepada Suruhanjaya Bursa Sekuriti (SEC).

Tarikh Fail Tarikh Tran Borang Simbol Saham Sekuriti Kod 10b5-1 Saham Baki Saham Peratus
Ubah Saham
harga Tran
Nilai Baki
Nilai

2019-06-03 2019-05-30 4 SENS Senseonics Holdings, Inc.
Stock Option (right to buy) A - Award 86,930 86,930

2019-01-04 2019-01-02 4 SENS Senseonics Holdings, Inc.
Common Stock A - Award 3,624 512,720 0.71 2.69 9,749 1,379,217

2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series D Preferred Stock C - Conversion -1,124,301 0 -100.00

2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock C - Conversion -437,706 0 -100.00

2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock S - Sale -4,349 437,706 -0.98 5.00 -21,745 2,188,530

2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock X - Other 181,190 442,055 69.46 0.12 21,743 53,047

2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series C-1 Preferred Stock X - Other -181,190 0 -100.00

2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series B Preferred Stock C - Conversion -3,279,627 0 -100.00

2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series B Preferred Stock S - Sale -1,177 3,279,627 -0.04 5.00 -5,885 16,398,135

2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series B Preferred Stock X - Other 49,030 3,280,804 1.52 0.12 5,884 393,696

2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series B Preferred Stock X - Other -49,030 0 -100.00

2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock P - Purchase 1,800,000 6,641,634 37.18 5.00 9,000,000 33,208,170

2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock C - Conversion 4,841,634 4,841,634

2018-10-15 2018-10-11 4 CLVS Clovis Oncology, Inc.
Stock Option (Right to Buy) A - Award 14,770 14,770

2018-10-03 2018-10-01 4 SENS Senseonics Holdings, Inc.
Common Stock A - Award 2,147 509,096 0.42 4.54 9,747 2,311,296

2018-09-10 2018-09-07 4 ADAP Adaptimmune Therapeutics PLC
Ordinary Shares with a nominal value of 0.001 GBP per share P - Purchase 3,000,000 82,978,668 3.75 1.67 5,000,100 138,300,546

2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Warrant to purchase Common Stock J - Other 40,702 40,702

2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Warrant to purchase Series D Preferred Stock J - Other -684,911 0 -100.00

2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Series D Preferred Stock C - Conversion -16,502,833 0 -100.00

2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Series C Preferred Stock C - Conversion -3,337,206 0 -100.00

2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Series B Preferred Stock C - Conversion -3,645,307 0 -100.00

2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Common Stock P - Purchase 545,455 2,484,870 28.12 11.00 6,000,005 27,333,570

2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Common Stock C - Conversion 980,715 1,939,415 102.30

2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Common Stock C - Conversion 432,033 958,700 82.03

2018-08-01 2018-07-30 4 LQDA Liquidia Technologies Inc
Common Stock C - Conversion 515,547 526,667 4,636.21

2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Class B Common Stock C - Conversion 346,239 7,729,641 4.69

2018-07-31 2018-07-27 4 BE Bloom Energy Corp
8% Convertible Preferred Notes C - Conversion -346,239 0 -100.00

2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Class B Common Stock C - Conversion 650,631 7,383,402 9.66

2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Series G Convertible Preferred Stock C - Conversion -650,631 0 -100.00

2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Class B Common Stock C - Conversion 125,989 6,732,771 1.91

2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Series F Convertible Preferred Stock C - Conversion -125,989 0 -100.00

2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Class B Common Stock C - Conversion 395,815 6,606,782 6.37

2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Series E Convertible Preferred Stock C - Conversion -395,815 0 -100.00

2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Class B Common Stock C - Conversion 620,155 6,210,967 11.09

2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Series D Convertible Preferred Stock C - Conversion -620,155 0 -100.00

2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Class B Common Stock C - Conversion 1,062,944 5,590,812 23.48

2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Series C Convertible Preferred Stock C - Conversion -1,062,944 0 -100.00

2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Class B Common Stock C - Conversion 4,527,868 4,527,868

2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Series B Convertible Preferred Stock C - Conversion -4,527,868 0 -100.00

2018-07-31 2018-07-27 4 BE Bloom Energy Corp
Class A Common Stock P - Purchase 1,333,333 1,333,333 15.00 19,999,995 19,999,995

2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock 22,240

2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock 22,240

2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock 22,240

2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock 22,240

2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock 22,240

2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock 22,240

2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock 22,240

2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock 22,240

2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock 22,240

2018-07-25 3 LQDA Liquidia Technologies Inc
Common Stock 22,240

2018-07-05 2018-07-02 4 SENS Senseonics Holdings, Inc.
Common Stock A - Award 2,200 506,949 0.44 4.43 9,746 2,245,784

2018-06-19 2018-06-15 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Stock Option (Right to Buy) A - Award 15,300 15,300

2018-06-01 2018-05-30 4 SENS Senseonics Holdings, Inc.
Stock Option (right to buy) A - Award 50,847 50,847

2018-05-30 2018-05-25 4 ARDX ARDELYX, INC.
Common Stock A - Award 416,667 9,169,210 4.76 4.00 1,666,668 36,676,840

2018-05-21 2018-05-18 4 GLYC GLYCOMIMETICS INC
Stock Option (right to buy) A - Award 11,000 11,000

2018-05-11 2018-05-10 4 GLYC GLYCOMIMETICS INC
Warrant to Purchase Common Stock (right to buy) X - Other -298,406 0 -100.00

2018-05-11 2018-05-10 4 GLYC GLYCOMIMETICS INC
Warrant to Purchase Common Stock (right to buy) X - Other -216,046 0 -100.00

2018-05-11 2018-05-10 4 GLYC GLYCOMIMETICS INC
Common Stock S - Sale -5,533 4,995,664 -0.11 17.81 -98,543 88,972,776

2018-05-11 2018-05-10 4 GLYC GLYCOMIMETICS INC
Common Stock X - Other 298,406 5,001,197 6.35 0.33 98,474 1,650,395

2018-05-11 2018-05-10 4 GLYC GLYCOMIMETICS INC
Common Stock S - Sale -4,006 4,702,791 -0.09 17.81 -71,347 83,756,708

2018-05-11 2018-05-10 4 GLYC GLYCOMIMETICS INC
Common Stock X - Other 216,046 4,706,797 4.81 0.33 71,295 1,553,243

2018-05-09 2018-05-01 4 MULE MULESOFT, INC
Class B Common Stock C - Conversion -12,679,970 0 -100.00

2018-05-09 2018-05-01 4 MULE MULESOFT, INC
Class A Common Stock U - Other -12,679,970 0 -100.00

2018-05-09 2018-05-01 4 MULE MULESOFT, INC
Class A Common Stock C - Conversion 12,679,970 12,679,970

2018-04-23 2018-04-23 4 SURF Surface Oncology, Inc.
Series A Preferred Stock C - Conversion -6,995,000 0 -100.00

2018-04-23 2018-04-23 4 SURF Surface Oncology, Inc.
Common Stock P - Purchase 133,333 3,312,877 4.19 15.00 1,999,995 49,693,155

2018-04-23 2018-04-23 4 SURF Surface Oncology, Inc.
Common Stock C - Conversion 3,179,544 3,179,544

2018-04-09 2018-04-02 4 SENS Senseonics Holdings, Inc.
Common Stock A - Award 3,145 504,749 0.63 3.10 9,750 1,564,722

2018-03-28 2018-03-27 4 ADAP Adaptimmune Therapeutics PLC
Ordinary Shares with a nominal value of 0.001 GBP per share P - Purchase 6,000,000 79,978,672 8.11 1.92 11,500,200 153,295,121

2018-03-28 2018-03-26 4 ADAP Adaptimmune Therapeutics PLC
Ordinary Shares with a nominal value of 0.001 GBP per share P - Purchase 571,164 73,978,672 0.78 1.90 1,087,553 140,862,789

2018-03-27 2018-03-27 4 TCON Tracon Pharmaceuticals, Inc.
Warrant to Purchase Common Stock P - Purchase 707,964 707,964 0.12 88,496 88,496

2018-03-27 2018-03-27 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock P - Purchase 707,964 3,466,003 25.67 2.70 1,911,503 9,358,208

2018-03-23 2018-03-23 4 ADAP Adaptimmune Therapeutics PLC
Ordinary Shares with a nominal value of 0.001 GBP per share P - Purchase 294,090 73,407,508 0.40 1.95 572,358 142,865,692

2018-03-23 2018-03-22 4 ADAP Adaptimmune Therapeutics PLC
Ordinary Shares with a nominal value of 0.001 GBP per share P - Purchase 869,574 73,113,418 1.20 1.90 1,655,669 139,207,948

2018-03-23 2018-03-21 4 ADAP Adaptimmune Therapeutics PLC
Ordinary Shares with a nominal value of 0.001 GBP per share P - Purchase 104,844 72,243,844 0.15 1.81 189,820 130,797,480

2018-03-06 2018-03-06 4 TSRO TESARO, Inc.
Common Stock P - Purchase 12,634 9,681,129 0.13 59.82 755,708 579,080,604

2018-03-06 2018-03-05 4 TSRO TESARO, Inc.
Common Stock P - Purchase 17,248 9,668,495 0.18 59.76 1,030,813 577,829,869

2018-03-06 2018-03-05 4 TSRO TESARO, Inc.
Common Stock P - Purchase 1,600 9,651,247 0.02 59.15 94,634 570,832,655

2018-03-06 2018-03-05 4 TSRO TESARO, Inc.
Common Stock P - Purchase 30,321 9,649,647 0.32 58.28 1,767,153 562,395,902

2018-03-06 2018-03-02 4 TSRO TESARO, Inc.
Common Stock P - Purchase 17,859 9,619,326 0.19 57.34 1,024,114 551,614,478

2018-03-06 2018-03-02 4 TSRO TESARO, Inc.
Common Stock P - Purchase 4,080 9,601,467 0.04 56.66 231,174 544,022,961

2018-03-06 2018-03-02 4 TSRO TESARO, Inc.
Common Stock P - Purchase 6,399 9,597,387 0.07 55.01 352,005 527,946,500

2018-03-06 2018-03-02 4 TSRO TESARO, Inc.
Common Stock P - Purchase 26,304 9,590,988 0.28 54.32 1,428,875 520,997,814

2018-03-02 2018-02-26 4 TNTR Tintri, Inc.
Note Purchase Agreement (obligation to purchase) E - Other 0

2018-02-21 2018-02-16 4 RARX Ra Pharmaceuticals, Inc.
Common Stock P - Purchase 2,000,000 5,490,073 57.31 6.00 12,000,000 32,940,438

2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class B Common Stock C - Conversion -2,724,202 0 -100.00

2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class A Common Stock J - Other 339 1,015 50.15

2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class A Common Stock J - Other 339 1,015 50.15

2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class A Common Stock J - Other 676 676

2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class A Common Stock J - Other 676 676

2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class A Common Stock J - Other -13,621 0 -100.00

2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class A Common Stock J - Other 13,621 13,621

2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class A Common Stock J - Other -27,242 0 -100.00

2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class A Common Stock J - Other 27,242 27,242

2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class A Common Stock J - Other -2,724,202 0 -100.00

2018-02-15 2018-02-13 4 APPN APPIAN CORP
Class A Common Stock C - Conversion 2,724,202 2,724,202

2018-01-26 2018-01-26 4 SYBX SYNLOGIC, INC.
Common Stock A - Award 410,000 4,228,940 10.74 9.75 3,997,500 41,232,165

2018-01-09 3 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 8,282,616

2018-01-09 3 SBBP Strongbridge Biopharma plc
Ordinary Shares, $0.01 par value 8,282,616

2018-01-04 2018-01-02 4 SENS Senseonics Holdings, Inc.
Common Stock A - Award 3,665 501,604 0.74 2.66 9,749 1,334,267

2017-12-19 2017-12-18 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Common Stock P - Purchase 2,000,000 5,554,610 56.26 5.00 10,000,000 27,773,050

2017-11-27 2017-11-27 4 APPN APPIAN CORP
Class B Common Stock C - Conversion -569,620 2,724,202 -17.29

2017-11-27 2017-11-27 4 APPN APPIAN CORP
Class A Common Stock S - Sale -569,620 0 -100.00 19.49 -11,101,894

2017-11-27 2017-11-27 4 APPN APPIAN CORP
Class A Common Stock C - Conversion 569,620 569,620

2017-11-21 2017-11-20 4 APPN APPIAN CORP
Class B Common Stock C - Conversion -2,820,516 3,293,822 -46.13

2017-11-21 2017-11-20 4 APPN APPIAN CORP
Class A Common Stock S - Sale -2,820,516 0 -100.00 19.49 -54,971,857

2017-11-21 2017-11-20 4 APPN APPIAN CORP
Class A Common Stock C - Conversion 2,820,516 2,820,516

2017-11-08 2017-11-06 4 CRCM Care.com Inc
Common Stock J - Other 252 252

2017-11-08 2017-11-06 4 CRCM Care.com Inc
Common Stock J - Other 252 252

2017-11-08 2017-11-06 4 CRCM Care.com Inc
Common Stock J - Other -10,000 0 -100.00

2017-11-08 2017-11-06 4 CRCM Care.com Inc
Common Stock J - Other 10,000 10,000

2017-11-08 2017-11-06 4 CRCM Care.com Inc
Common Stock J - Other -1,000,000 2,256,013 -30.71

2017-10-16 2017-10-12 4 SENS Senseonics Holdings, Inc.
Common Stock A - Award 3,250 497,939 0.66

2017-10-10 2017-10-10 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Series A-1 Junior Preferred Stock C - Conversion -2,927,708 0 -100.00

2017-10-10 2017-10-10 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Series A Preferred Stoc C - Conversion -1,402,870 0 -100.00

2017-10-10 2017-10-10 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock P - Purchase 550,000 4,909,956 12.61 17.00 9,350,000 83,469,252

2017-10-10 2017-10-10 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock C - Conversion 2,927,708 4,359,956 204.41

2017-10-10 2017-10-10 4 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock C - Conversion 1,402,870 1,432,248 4,775.24

2017-10-04 3 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock 58,756

2017-10-04 3 RYTM RHYTHM PHARMACEUTICALS, INC.
Common Stock 58,756

2017-08-30 2017-08-28 4 SYBX SYNLOGIC, INC.
Common Stock A - Award 3,394,439 3,818,940 799.63

2017-08-07 2017-08-03 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Stock Option (Right to Buy) A - Award 63,663 63,663

2017-07-06 2017-07-03 4 MRSN Mersana Therapeutics, Inc.
Series C-1 Preferred Stock C - Conversion -2,216,626 0 -100.00

2017-07-06 2017-07-03 4 MRSN Mersana Therapeutics, Inc.
Series B-1 Preferred Stock C - Conversion -18,001,419 0 -100.00

2017-07-06 2017-07-03 4 MRSN Mersana Therapeutics, Inc.
Series A-1 Preferred Stock C - Conversion -11,931,173 0 -100.00

2017-07-06 2017-07-03 4 MRSN Mersana Therapeutics, Inc.
Common Stock P - Purchase 1,000,000 8,140,138 14.01 15.00 15,000,000 122,102,070

2017-07-06 2017-07-03 4 MRSN Mersana Therapeutics, Inc.
Common Stock C - Conversion 7,140,138 7,140,138

2017-06-30 2017-06-28 4 ROKA Roka BioScience, Inc.
Stock Option (right to buy) A - Award -3,000 3,000 -50.00

2017-06-08 2017-06-08 4 CLVS Clovis Oncology, Inc.
Stock Option (Right to Buy) A - Award 10,000 10,000

2017-06-05 2017-06-01 4 SENS Senseonics Holdings, Inc.
Common Stock P - Purchase 7,092,198 21,911,183 47.86 1.41 9,999,999 30,894,768

2017-05-31 2017-05-31 4 APPN APPIAN CORP
Class B Common Stock C - Conversion 6,114,338 6,114,338

2017-05-31 2017-05-31 4 APPN APPIAN CORP
Series B Convertible Preferred Stock C - Conversion -6,114,338 0 -100.00

2017-05-30 2017-05-25 4 GLYC GLYCOMIMETICS INC
Stock Option (right to buy) A - Award 11,000 11,000

2017-05-26 2017-05-24 4 SENS Senseonics Holdings, Inc.
Stock Option (right to buy) A - Award 128,817 128,817

2017-03-28 2017-03-27 4 ADAP Adaptimmune Therapeutics PLC
Ordinary Shares with a nominal value of 0.001 GBP per share P - Purchase 12,870,000 72,139,000 21.71 0.70 9,009,000 50,497,300

2017-03-22 2017-03-22 4 MULE MULESOFT, INC
Class B Common Stock J - Other 12,679,970 12,679,970

2017-03-22 2017-03-22 4 MULE MULESOFT, INC
Series G Preferred Stock C - Conversion -605,668 0 -100.00

2017-03-22 2017-03-22 4 MULE MULESOFT, INC
Series F Preferred Stock C - Conversion -2,064,048 0 -100.00

2017-03-22 2017-03-22 4 MULE MULESOFT, INC
Series E Preferred Stock C - Conversion -8,000,038 0 -100.00

2017-03-22 2017-03-22 4 MULE MULESOFT, INC
Series A Preferred Stock C - Conversion -1,689,436 0 -100.00

2017-03-22 2017-03-22 4 MULE MULESOFT, INC
Common Stock J - Other -12,679,970 0 -100.00

2017-03-22 2017-03-22 4 MULE MULESOFT, INC
Common Stock C - Conversion 12,359,190 12,679,970 3,852.86

2017-03-16 3 MULE MULESOFT, INC
Common Stock 641,560

2017-03-16 3 MULE MULESOFT, INC
Common Stock 641,560

2017-03-01 2017-02-27 4 CLVS Clovis Oncology, Inc.
Common Stock J - Other 287 861 50.00

2017-03-01 2017-02-27 4 CLVS Clovis Oncology, Inc.
Common Stock J - Other 287 861 50.00

2017-03-01 2017-02-27 4 CLVS Clovis Oncology, Inc.
Common Stock J - Other -11,399 0 -100.00

2017-03-01 2017-02-27 4 CLVS Clovis Oncology, Inc.
Common Stock J - Other 11,399 11,399

2017-03-01 2017-02-27 4 CLVS Clovis Oncology, Inc.
Common Stock J - Other -1,139,890 0 -100.00

2017-02-14 2017-02-13 4 ZSAN Zosano Pharma Corp
Common Stock S - Sale -1,099,996 952,809 -53.59 2.01 -2,211,432 1,915,527

2016-11-29 2016-11-29 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock P - Purchase 869,565 2,758,039 46.05 5.75 4,999,999 15,858,724

2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Series B-2 Preferred Stock C - Conversion -4,362,472 0 -100.00

2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Series B-1 Preferred Stock C - Conversion -4,689,657 0 -100.00

2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Series A Preferred Stock C - Conversion -12,447,605 0 -100.00

2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Warrants to Purchase Common Stock X - Other -80,658 0 -100.00

2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Common Stock P - Purchase 338,462 3,490,073 10.74 13.00 4,400,006 45,370,949

2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Common Stock C - Conversion 623,210 3,151,611 24.65

2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Common Stock C - Conversion 669,951 2,528,401 36.05

2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Common Stock C - Conversion 1,778,227 1,858,450 2,216.60

2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Common Stock S - Sale -435 80,223 -0.54 13.00 -5,655 1,042,899

2016-10-31 2016-10-31 4 RARX Ra Pharmaceuticals, Inc.
Common Stock X - Other 80,658 80,658 0.07 5,646 5,646

2016-09-30 2016-09-21 4/A ROKA Roka BioScience, Inc.
Series A Convertible Preferred Stock P - Purchase 4,000 4,000

2016-09-23 2016-09-21 4 ROKA Roka BioScience, Inc.
Warrant to Purchase Common Stock (right to buy) P - Purchase 5,714,286 5,714,286

2016-09-23 2016-09-21 4 ROKA Roka BioScience, Inc.
Series A Convertible Preferred Stock P - Purchase 4,000 4,000

2016-09-20 2016-09-16 4 ZSAN Zosano Pharma Corp
Common Stock S - Sale -7,471 2,052,805 -0.36 0.75 -5,603 1,539,604

2016-09-15 2016-09-13 4 ZSAN Zosano Pharma Corp
Common Stock S - Sale -10,000 2,060,276 -0.48 0.74 -7,400 1,524,604

2016-09-15 2016-09-14 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Common Stock P - Purchase 461,538 3,554,610 14.92 13.00 5,999,994 46,209,930

2016-08-31 2016-08-29 4 ZSAN Zosano Pharma Corp
Common Stock S - Sale -50,000 2,070,276 -2.36 1.01 -50,440 2,088,494

2016-08-26 2016-08-24 4 ZSAN Zosano Pharma Corp
Common Stock S - Sale -1,200 2,120,276 -0.06 1.21 -1,452 2,565,534

2016-08-02 2016-07-29 4 ILIU INTERLEUKIN GENETICS INC
Common Stock Warrant (right to buy) P - Purchase 20,120,724 20,120,724

2016-08-02 2016-07-29 4 ILIU INTERLEUKIN GENETICS INC
Common Stock P - Purchase 20,120,724 55,418,811 57.00 0.10 2,000,000 5,508,630

2016-07-21 2016-07-21 4 ZSAN Zosano Pharma Corp
Common Stock S - Sale -8,989 2,121,476 -0.42 1.33 -11,957 2,821,987

2016-07-21 2016-07-20 4 ZSAN Zosano Pharma Corp
Common Stock S - Sale -14,158 2,130,465 -0.66 1.24 -17,550 2,640,924

2016-07-21 2016-07-19 4 ZSAN Zosano Pharma Corp
Common Stock S - Sale -534 2,144,623 -0.02 1.17 -625 2,509,209

2016-07-20 2016-07-18 4 ARDX ARDELYX, INC.
Common Stock P - Purchase 763,650 8,752,543 9.56 8.73 6,666,664 76,409,700

2016-07-15 2016-07-13 4 ZSAN Zosano Pharma Corp
Common Stock S - Sale -13,382 2,145,157 -0.62 1.20 -16,060 2,574,403

2016-06-24 2016-06-22 4 ROKA Roka BioScience, Inc.
Stock Option (right to buy) A - Award -30,000 30,000 -50.00

2016-06-14 2016-06-14 4 OPWR OPOWER, INC.
Common Stock U - Other -8,989,766 0 -100.00 10.30 -92,594,590

2016-06-13 2016-06-09 4 CLVS Clovis Oncology, Inc.
Stock Option (Right to Buy) A - Award 10,000 10,000

2016-05-26 2016-05-24 4 SENS Senseonics Holdings, Inc.
Stock Option (right to buy) A - Award 54,629 54,629

2016-05-19 2016-05-17 4 GLYC GLYCOMIMETICS INC
Stock Option (right to buy) A - Award 11,000 11,000

2016-03-24 2016-03-16 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock G - Gift -18,000 97,355 -15.60

2016-03-23 2016-03-23 4 SENS Senseonics Holdings, Inc.
Common Stock P - Purchase 1,578,947 14,818,985 11.93 2.85 4,499,999 42,234,107

2016-03-18 2016-03-18 4 TSRO TESARO, Inc.
Common Stock P - Purchase 710,429 9,564,684 8.02 35.19 24,999,997 336,581,230

2016-03-17 3 SENS Senseonics Holdings, Inc.
Common Stock 14,381,495

2016-03-17 3 SENS Senseonics Holdings, Inc.
Common Stock 14,038,885

2016-03-17 3 SENS Senseonics Holdings, Inc.
Common Stock 27,126,844

2016-03-17 3 SENS Senseonics Holdings, Inc.
Common Stock 14,381,495

2016-03-17 3 SENS Senseonics Holdings, Inc.
Common Stock 14,038,885

2016-03-17 3 SENS Senseonics Holdings, Inc.
Common Stock 27,126,844

2016-03-03 2016-03-01 4 SUPN SUPERNUS PHARMACEUTICALS INC
Director Stock Option (Right to Buy) A - Award 15,000 15,000

2016-02-17 2016-02-17 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Series B Convertible Redeemable Preferred Stock C - Conversion -4,423,723 0 -100.00

2016-02-17 2016-02-17 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Series A Convertible Preferred Stock C - Conversion -13,848,000 0 -100.00

2016-02-17 2016-02-17 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Common Stock P - Purchase 900,324 3,093,072 41.06 8.00 7,202,592 24,744,576

2016-02-17 2016-02-17 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Common Stock C - Conversion 2,192,748 2,192,748

2016-02-12 2016-02-10 4 PTI PROTEOSTASIS THERAPEUTICS, INC.
Stock Option (Right to Buy) A - Award 45,760 45,760

2016-02-04 2016-02-03 4 TRIV TriVascular Technologies, Inc.
Common Stock D - Sale to Issuer -3,943,269 0 -100.00

2016-01-14 2016-01-13 4 ARDX ARDELYX, INC.
Common Stock P - Purchase 500,000 7,988,893 6.68 10.00 5,000,000 79,888,930

2016-01-12 2016-01-12 4 EPZM Epizyme, Inc.
Common Stock P - Purchase 1,111,111 5,854,351 23.43 9.00 9,999,999 52,689,159

2016-01-04 3 ADAP Adaptimmune Therapeutics PLC
Ordinary Shares with a nominal value of 0.001 GBP per share 118,538,000

2016-01-04 3 ADAP Adaptimmune Therapeutics PLC
Ordinary Shares with a nominal value of 0.001 GBP per share 118,538,000

2015-12-08 2015-12-08 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock S - Sale -70,913 0 -100.00 14.75 -1,045,953

2015-12-08 2015-12-07 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock S - Sale -71,067 70,913 -50.05 14.38 -1,022,192 1,019,977

2015-12-08 2015-12-04 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock S - Sale -70,990 141,980 -33.33 14.54 -1,032,152 2,064,304

2015-12-03 2015-12-03 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other 212,970 212,970

2015-12-03 2015-12-03 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other 8,733 24,317 56.04

2015-12-03 2015-12-03 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other 11,980 33,360 56.03

2015-12-03 2015-12-03 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other 20,713 57,678 56.03

2015-12-03 2015-12-03 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other 41,426 115,355 56.03

2015-12-03 2015-12-03 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other -1,172,932 0 -100.00

2015-12-03 2015-12-03 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other 1,172,932 1,172,932

2015-12-03 2015-12-03 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other -3,820,625 0 -100.00

2015-11-30 2015-11-25 4 SUPN SUPERNUS PHARMACEUTICALS INC
Director Stock Option (Right to Buy) M - Exercise -7,457 0 -100.00

2015-11-30 2015-11-25 4 SUPN SUPERNUS PHARMACEUTICALS INC
Director Stock Option (Right to Buy) M - Exercise -8,722 0 -100.00

2015-11-30 2015-11-25 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock S - Sale -16,179 73,929 -17.96 16.35 -264,494 1,208,591

2015-11-30 2015-11-25 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock M - Exercise 7,457 90,108 9.02 9.24 68,903 832,598

2015-11-30 2015-11-25 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock M - Exercise 8,722 82,651 11.80 7.90 68,904 652,943

2015-11-18 2015-11-16 4 GLYC GLYCOMIMETICS INC
Warrant to Purchase Common Stock (right to buy) X - Other -9,445 0 -100.00 0.33 -3,117

2015-11-18 2015-11-16 4 GLYC GLYCOMIMETICS INC
Common Stock S - Sale -452 4,490,751 -0.01 6.91 -3,123 31,031,089

2015-11-18 2015-11-16 4 GLYC GLYCOMIMETICS INC
Common Stock X - Other 9,445 4,491,203 0.21 0.33 3,117 1,482,097

2015-11-18 2015-11-18 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock S - Sale -43,000 0 -100.00 16.50 -709,543

2015-11-18 2015-11-17 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock S - Sale -50,000 43,000 -53.76 16.71 -835,460 718,496

2015-11-17 2015-11-16 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock S - Sale -19,650 93,000 -17.44 16.13 -317,035 1,500,471

2015-11-17 2015-11-13 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock S - Sale -100,000 112,650 -47.03 16.26 -1,625,610 1,831,250

2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other 212,650 212,650

2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other 8,728 15,584 127.30

2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other 11,974 21,380 127.30

2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other 20,703 36,965 127.31

2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other 41,405 73,929 127.31

2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other -1,172,932 0 -100.00

2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other 1,172,932 1,172,932

2015-11-12 2015-11-11 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other -3,820,625 3,820,625 -50.00

2015-10-20 2015-10-20 4 CERC Cerecor Inc.
Series B Convertible Preferred Stock C - Conversion -16,638,880 0 -100.00

2015-10-20 2015-10-20 4 CERC Cerecor Inc.
Common Stock C - Conversion 594,245 594,245

2015-10-06 2015-10-06 4 MIRN Mirna Therapeutics, Inc.
Common Stock P - Purchase 857,142 2,971,517 40.54 7.00 5,999,994 20,800,619

2015-10-06 2015-10-06 4 MIRN Mirna Therapeutics, Inc.
Common Stock J - Other 31,650 2,114,375 1.52

2015-10-06 2015-10-06 4 MIRN Mirna Therapeutics, Inc.
Common Stock J - Other 257,516 1,499,166 20.74

2015-10-06 2015-10-05 4 MIRN Mirna Therapeutics, Inc.
Series D Preferred Stock C - Conversion -583,559 0 -100.00

2015-10-06 2015-10-05 4 MIRN Mirna Therapeutics, Inc.
Series C Preferred Stock C - Conversion -1,241,650 0 -100.00

2015-10-06 2015-10-05 4 MIRN Mirna Therapeutics, Inc.
Common Stock C - Conversion 583,559 2,082,725 38.93

2015-10-06 2015-10-05 4 MIRN Mirna Therapeutics, Inc.
Common Stock C - Conversion 1,241,650 1,241,650

2015-08-11 2015-07-15 4 GLYC GLYCOMIMETICS INC
Stock Option (right to buy) A - Award 11,000 11,000

2015-07-30 2015-07-28 4 LOXO Loxo Oncology, Inc.
Director Stock Option (right to buy) A - Award 7,812 7,812

2015-07-02 2015-07-01 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock J - Other 464 464

2015-07-02 2015-07-01 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock J - Other 1,134 1,134

2015-07-02 2015-07-01 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock I - Other -8,250 0 -100.00

2015-07-02 2015-07-01 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock J - Other 8,250 8,250

2015-07-02 2015-07-01 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock J - Other -825,000 1,786,564 -31.59

2015-06-26 2015-06-24 4 ROKA Roka BioScience, Inc.
Stock Option (right to buy) A - Award -15,000 15,000 -50.00

2015-06-19 2015-06-17 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock S - Sale -48,796 0 -100.00 16.02 -781,800

2015-06-19 2015-06-17 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock S - Sale -63,085 48,796 -56.39 16.67 -1,051,804 813,566

2015-06-17 2015-06-16 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock S - Sale -55,105 111,881 -33.00 16.85 -928,668 1,885,497

2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other 166,986 166,986

2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other 6,856 6,856

2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other 9,406 9,406

2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other 16,262 16,262

2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other 32,524 32,524

2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other -921,000 921,000 -50.00

2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other 921,000 921,000

2015-06-17 2015-06-15 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock J - Other -3,000,000 7,641,250 -28.19

2015-06-15 2015-06-11 4 CLVS Clovis Oncology, Inc.
Stock Option (Right to Buy) A - Award 10,000 10,000

2015-06-09 2015-06-05 4 ARDX ARDELYX, INC.
Common Stock Warrant (right to buy) P - Purchase 560,748 560,748 0.12 70,094 70,094

2015-06-09 2015-06-05 4 ARDX ARDELYX, INC.
Common Stock P - Purchase 1,869,159 7,488,893 33.26 10.70 20,000,001 80,131,155

2015-06-04 2015-06-02 4 TSRO TESARO, Inc.
Common Stock S - Sale -629 0 -100.00 58.13 -36,564

2015-06-04 2015-06-02 4 TSRO TESARO, Inc.
Common Stock S - Sale -1,500 629 -70.46 57.55 -86,332 36,202

2015-06-02 2015-06-01 4 TSRO TESARO, Inc.
Common Stock J - Other 252 252

2015-06-02 2015-06-01 4 TSRO TESARO, Inc.
Common Stock J - Other 252 252

2015-06-02 2015-06-01 4 TSRO TESARO, Inc.
Common Stock J - Other 2,129 2,129

2015-06-02 2015-06-01 4 TSRO TESARO, Inc.
Common Stock J - Other -10,000 0 -100.00

2015-06-02 2015-06-01 4 TSRO TESARO, Inc.
Common Stock J - Other 10,000 10,000

2015-06-02 2015-06-01 4 TSRO TESARO, Inc.
Common Stock J - Other -1,000,000 8,854,255 -10.15

2015-05-15 2015-05-15 4 CLVS Clovis Oncology, Inc.
Common Stock S - Sale -1,924 0 -100.00 92.57 -178,107

2015-05-15 2015-05-15 4 CLVS Clovis Oncology, Inc.
Common Stock S - Sale -500 1,924 -20.63 91.86 -45,932 176,746

2015-05-15 2015-05-14 4 CLVS Clovis Oncology, Inc.
Common Stock J - Other 2,424 2,424

2015-05-15 2015-05-14 4 CLVS Clovis Oncology, Inc.
Common Stock J - Other 287 574 100.00

2015-05-15 2015-05-14 4 CLVS Clovis Oncology, Inc.
Common Stock J - Other 287 574 100.00

2015-05-15 2015-05-14 4 CLVS Clovis Oncology, Inc.
Common Stock J - Other -11,399 0 -100.00

2015-05-15 2015-05-14 4 CLVS Clovis Oncology, Inc.
Common Stock J - Other 11,399 11,399

2015-05-15 2015-05-14 4 CLVS Clovis Oncology, Inc.
Common Stock J - Other -1,139,891 1,139,890 -50.00

2015-05-11 2015-05-07 4 HPTX HYPERION THERAPEUTICS INC
Common Stock U - Other -2,384,221 0 -100.00 46.00 -109,674,166

2015-03-24 3 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock 37,500,000

2015-03-24 3 CSBR CHAMPIONS ONCOLOGY, INC.
Common Stock 37,500,000

2015-03-05 2015-03-03 4 SUPN SUPERNUS PHARMACEUTICALS INC
Director Stock Option (Right to Buy) A - Award 20,000 20,000

2015-02-05 2015-02-04 4 TCON Tracon Pharmaceuticals, Inc.
Series B Redeemable Convertible Preferred Stock C - Conversion -5,373,396 0 -100.00

2015-02-05 2015-02-04 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock P - Purchase 500,000 1,888,474 36.01 10.00 5,000,000 18,884,740

2015-02-05 2015-02-04 4 TCON Tracon Pharmaceuticals, Inc.
Common Stock C - Conversion 1,388,474 1,388,474

2015-02-02 2015-01-30 4 ZSAN Zosano Pharma Corp
8% Convertible Note Issued 9/9/2013 C - Conversion

2015-02-02 2015-01-30 4 ZSAN Zosano Pharma Corp
8% Convertible Note Issued 12/2/2014 C - Conversion

2015-02-02 2015-01-30 4 ZSAN Zosano Pharma Corp
8% Convertible Note Issued 2/26/2014 C - Conversion

2015-02-02 2015-01-30 4 ZSAN Zosano Pharma Corp
Common Stock P - Purchase 23,457 2,158,539 1.10 11.00 258,027 23,743,929

2015-02-02 2015-01-30 4 ZSAN Zosano Pharma Corp
Common Stock C - Conversion 341,201 2,135,082 19.02 9.35 3,190,229 19,963,017

2015-01-29 2015-01-28 4 BOX BOX INC
Class B Common Stock J - Other 2,091,457 2,091,457

2015-01-29 2015-01-28 4 BOX BOX INC
Series E Preferred Stock C - Conversion -274,916 0 -100.00

2015-01-29 2015-01-28 4 BOX BOX INC
Series D2 Preferred Stock C - Conversion -1,653,761 0 -100.00

2015-01-29 2015-01-28 4 BOX BOX INC
Existing Class A Common Stock J - Other -2,091,457 0 -100.00

2015-01-29 2015-01-28 4 BOX BOX INC
Existing Class A Common Stock C - Conversion 1,928,677 2,091,457 1,184.84

2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock 1,793,891

2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock 3,587,767

2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock 1,793,891

2015-01-26 3 ZSAN Zosano Pharma Corp
Common Stock 3,587,767

2015-01-22 3 BOX BOX INC
Existing Class A Common Stock 325,560

2015-01-22 3 BOX BOX INC
Existing Class A Common Stock 325,560

2014-12-29 2014-12-23 4 ARDX ARDELYX, INC.
Common Stock J - Other -10,000 0 -100.00

2014-12-29 2014-12-26 4 ARDX ARDELYX, INC.
Common Stock S - Sale -1,972 0 -100.00 21.28 -41,961

2014-12-29 2014-12-26 4 ARDX ARDELYX, INC.
Common Stock S - Sale -296 0 -100.00 21.54 -6,377

2014-12-29 2014-12-26 4 ARDX ARDELYX, INC.
Common Stock S - Sale -296 5,619,734 -0.01 21.54 -6,377 121,076,607

2014-12-29 2014-12-23 4 ARDX ARDELYX, INC.
Common Stock J - Other 1,972 1,972

2014-12-29 2014-12-23 4 ARDX ARDELYX, INC.
Common Stock J - Other 296 296

2014-12-29 2014-12-23 4 ARDX ARDELYX, INC.
Common Stock J - Other 296 296

2014-12-29 2014-12-23 4 ARDX ARDELYX, INC.
Common Stock J - Other -10,000 0 -100.00

2014-12-29 2014-12-23 4 ILIU INTERLEUKIN GENETICS INC
Common Stock Warrant (right to buy) P - Purchase 19,868,965 19,868,965

2014-12-29 2014-12-23 4 ILIU INTERLEUKIN GENETICS INC
Common Stock P - Purchase 19,868,965 35,298,087 128.78 0.10 1,992,857 3,540,398

2014-12-22 2014-12-22 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -55,994 3,569,210 -1.54 8.01 -448,512 28,589,372

2014-12-22 2014-12-19 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -27,790 3,625,204 -0.76 7.91 -219,683 28,657,600

2014-12-18 2014-12-18 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -52,998 3,652,994 -1.43 7.90 -418,742 28,862,671

2014-12-18 2014-12-17 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -63,094 3,705,992 -1.67 7.72 -487,269 28,621,006

2014-12-18 2014-12-16 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -27,233 3,769,086 -0.72 7.76 -211,238 29,235,669

2014-12-16 2014-12-12 4 ARDX ARDELYX, INC.
Common Stock J - Other -1,000,000 5,619,734 -15.11

2014-12-15 2014-12-15 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -16,859 3,796,319 -0.44 7.82 -131,827 29,684,937

2014-12-15 2014-12-12 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -56,420 3,813,178 -1.46 7.93 -447,174 30,222,486

2014-12-15 2014-12-11 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -53,182 3,869,598 -1.36 7.92 -421,201 30,647,216

2014-12-10 2014-12-10 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -31,220 3,922,780 -0.79 7.87 -245,804 30,885,224

2014-12-10 2014-12-09 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -26,992 3,954,000 -0.68 7.79 -210,195 30,790,984

2014-12-10 2014-12-08 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -21,448 3,980,992 -0.54 7.71 -165,340 30,689,069

2014-12-10 2014-12-10 4 TRVN TREVENA INC
Common Stock P - Purchase 1,000,000 4,811,691 26.24 4.00 4,000,000 19,246,764

2014-12-05 2014-12-05 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -18,959 4,002,440 -0.47 7.83 -148,525 31,355,115

2014-12-05 2014-12-04 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -38,061 4,021,399 -0.94 7.83 -297,903 31,475,490

2014-12-05 2014-12-03 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -46,635 4,059,460 -1.14 7.92 -369,405 32,155,795

2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class B Common Stock C - Conversion -1,250,000 1,964,192 -38.89

2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock J - Other 69,572 69,572

2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock J - Other 3,920 3,920

2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock J - Other 2,857 2,857

2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock J - Other 6,777 6,777

2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock J - Other 13,553 20,522 194.48

2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock J - Other -383,750 0 -100.00

2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock J - Other 383,750 383,750

2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock J - Other -1,250,000 0 -100.00

2014-12-04 2014-12-02 4 DATA Tableau Software Inc
Class A Common Stock C - Conversion 1,250,000 1,250,000

2014-12-02 2014-12-02 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -61,569 4,106,095 -1.48 7.90 -486,432 32,440,614

2014-12-02 2014-12-01 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -24,796 4,167,664 -0.59 7.89 -195,519 32,862,447

2014-12-02 2014-11-28 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -50,500 4,192,460 -1.19 7.99 -403,515 33,499,432

2014-11-28 2014-11-25 4 CVT CVENT INC
Common Stock J - Other 2,639 2,639

2014-11-28 2014-11-25 4 CVT CVENT INC
Common Stock J - Other 252 252

2014-11-28 2014-11-25 4 CVT CVENT INC
Common Stock J - Other 252 252

2014-11-28 2014-11-25 4 CVT CVENT INC
Common Stock J - Other -10,000 0 -100.00

2014-11-28 2014-11-25 4 CVT CVENT INC
Common Stock J - Other 10,000 10,000

2014-11-28 2014-11-25 4 CVT CVENT INC
Common Stock J - Other -1,000,000 3,994,106 -20.02

2014-11-26 2014-11-26 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -76,600 4,242,960 -1.77 8.01 -613,221 33,967,016

2014-11-26 2014-11-25 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -50,000 4,319,560 -1.14 7.90 -394,990 34,123,660

2014-11-26 2014-11-24 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -23,400 4,369,560 -0.53 7.72 -180,566 33,717,710

2014-11-21 2014-11-21 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -24,459 4,392,960 -0.55 7.66 -187,395 33,657,102

2014-11-21 2014-11-20 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -21,550 4,417,419 -0.49 7.69 -165,655 33,956,700

2014-11-21 2014-11-19 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -28,991 4,438,969 -0.65 7.69 -223,063 34,154,315

2014-10-08 2014-10-08 4 DERM Dermira, Inc.
Series C Preferred Stock C - Conversion -382,840 0 -100.00

2014-10-08 2014-10-08 4 DERM Dermira, Inc.
Series B Preferred Stock C - Conversion -655,321 0 -100.00

2014-10-08 2014-10-08 4 DERM Dermira, Inc.
Series A Preferred Stock C - Conversion -2,378,408 0 -100.00

2014-10-08 2014-10-08 4 DERM Dermira, Inc.
Common Stock P - Purchase 69,112 3,502,922 2.01 16.00 1,105,792 56,046,752

2014-10-08 2014-10-08 4 DERM Dermira, Inc.
Common Stock C - Conversion 3,416,569 3,433,810 19,816.54

2014-10-02 3 DERM Dermira, Inc.
Common Stock 34,482

2014-10-02 3 DERM Dermira, Inc.
Common Stock 34,482

2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Series C Preferred Stock C - Conversion -58,692 0 -100.00

2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Series B Preferred Stock C - Conversion -1,479,058 0 -100.00

2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock C - Conversion -172,825 0 -100.00

2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock P - Purchase 813,474 2,611,564 45.24 8.00 6,507,792 20,892,512

2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock C - Conversion 58,692 1,798,090 3.37

2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock C - Conversion 1,479,058 1,739,398 568.13

2014-10-01 2014-09-29 4 VTAE Vitae Pharmaceuticals, Inc
Common Stock C - Conversion 260,340 260,340

2014-08-29 2014-08-29 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock S - Sale -11,600 4,659,333 -0.25 7.51 -87,070 34,972,953

2014-08-29 2014-08-28 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock S - Sale -146,800 4,670,933 -3.05 7.87 -1,154,846 36,745,296

2014-08-29 2014-08-27 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock S - Sale -108,300 4,817,733 -2.20 8.17 -884,811 39,360,879

2014-08-26 2014-08-25 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -7,099 0 -100.00 60.40 -428,773

2014-08-25 2014-08-22 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -27,921 7,099 -79.73 61.02 -1,703,739 433,181

2014-08-25 2014-08-22 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -24,391 35,020 -41.05 60.46 -1,474,680 2,117,309

2014-08-22 2014-08-21 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -8,712 0 -100.00 59.89 -521,728

2014-08-22 2014-08-21 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -100 0 -100.00 60.65 -6,065

2014-08-22 2014-08-21 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -4,939 100 -98.02 59.49 -293,811 5,949

2014-08-22 2014-08-21 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -343 0 -100.00 59.70 -20,478

2014-08-22 2014-08-21 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -3,330 343 -90.66 60.02 -199,857 20,586

2014-08-22 2014-08-21 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -400 6,969 -5.43 60.56 -24,223 422,017

2014-08-22 2014-08-21 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -10,055 7,369 -57.71 59.73 -600,618 440,175

2014-08-22 2014-08-21 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -9,348 59,411 -13.60 59.79 -558,917 3,552,184

2014-08-22 2014-08-21 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -20,652 68,759 -23.10 59.19 -1,222,392 4,069,845

2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class B Common Stock C - Conversion -1,607,096 3,214,192 -33.33

2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock J - Other 89,411 89,411

2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock J - Other 5,039 5,039

2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock J - Other 3,673 3,673

2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock J - Other 8,712 8,712

2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock J - Other 17,424 17,424

2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock J - Other -493,378 0 -100.00

2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock J - Other 493,378 493,378

2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock J - Other -1,607,096 0 -100.00

2014-08-22 2014-08-20 4 DATA Tableau Software Inc
Class A Common Stock C - Conversion 1,607,096 1,607,096

2014-08-18 2014-08-15 4 EPZM Epizyme, Inc.
Common Stock S - Sale -384 0 -100.00 36.94 -14,185

2014-08-18 2014-08-15 4 EPZM Epizyme, Inc.
Common Stock S - Sale -3,027 384 -88.74 36.45 -110,334 13,997

2014-08-18 2014-08-15 4 EPZM Epizyme, Inc.
Common Stock S - Sale -325 0 -100.00 35.93 -11,676

2014-08-18 2014-08-15 4 EPZM Epizyme, Inc.
Common Stock S - Sale -325 0 -100.00 35.67 -11,593

2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock J - Other 3,411 3,411

2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock J - Other 325 325

2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock J - Other 325 406,825 0.08

2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock J - Other -12,900 0 -100.00

2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock J - Other 12,900 12,900

2014-08-18 2014-08-14 4 EPZM Epizyme, Inc.
Common Stock J - Other -1,290,000 4,743,240 -21.38

2014-08-18 2014-08-15 4 CVT CVENT INC
Common Stock S - Sale -2,641 0 -100.00 26.19 -69,174

2014-08-18 2014-08-15 4 CVT CVENT INC
Common Stock S - Sale -252 0 -100.00 26.22 -6,608

2014-08-18 2014-08-15 4 CVT CVENT INC
Common Stock S - Sale -252 0 -100.00 26.26 -6,616

2014-08-18 2014-08-14 4 CVT CVENT INC
Common Stock J - Other 2,641 2,641

2014-08-18 2014-08-14 4 CVT CVENT INC
Common Stock J - Other 252 252

2014-08-18 2014-08-14 4 CVT CVENT INC
Common Stock J - Other 252 252

2014-08-18 2014-08-14 4 CVT CVENT INC
Common Stock J - Other -10,000 0 -100.00

2014-08-18 2014-08-14 4 CVT CVENT INC
Common Stock J - Other 10,000 10,000

2014-08-18 2014-08-14 4 CVT CVENT INC
Common Stock J - Other -1,000,000 4,994,106 -16.68

2014-08-12 2014-08-12 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock S - Sale -35,540 4,926,033 -0.72 6.76 -240,190 33,291,609

2014-08-12 2014-08-08 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock S - Sale -675,000 4,961,573 -11.98 6.62 -4,468,568 32,846,109

2014-08-06 2014-08-06 4 LOXO Loxo Oncology, Inc.
Series B Convertible Preferred Stock C - Conversion -1,558,651 0 -100.00

2014-08-06 2014-08-06 4 LOXO Loxo Oncology, Inc.
Common Stock P - Purchase 230,769 1,789,420 14.81 13.00 2,999,997 23,262,460

2014-08-06 2014-08-06 4 LOXO Loxo Oncology, Inc.
Common Stock C - Conversion 1,558,651 1,558,651

2014-08-01 2014-07-31 4 LOXO Loxo Oncology, Inc.
Director Stock Option (right to buy) A - Award 15,625 15,625

2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Series E Preferred Stock C - Conversion -5,987,892 0 -100.00

2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Series D Preferred Stock C - Conversion -8,555,784 0 -100.00

2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Series C Preferred Stock C - Conversion -4,030,224 0 -100.00

2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Series B Preferred Stock C - Conversion -12,360,000 0 -100.00

2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock P - Purchase 383,333 3,216,810 13.53 12.00 4,599,996 38,601,720

2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock C - Conversion 542,381 2,833,477 23.67

2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock C - Conversion 801,741 2,291,096 53.83

2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock C - Conversion 365,056 1,489,355 32.47

2014-07-22 2014-07-22 4 ROKA Roka BioScience, Inc.
Common Stock C - Conversion 1,119,565 1,124,299 23,649.45

2014-07-16 3 ROKA Roka BioScience, Inc.
Common Stock 9,468

2014-07-16 3 ROKA Roka BioScience, Inc.
Common Stock 9,468

2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock C - Conversion -72,190 0 -100.00

2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock J - Other -468 72,190 -0.64 14.00 -6,552 1,010,660

2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock X - Other 72,658 72,658

2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock Purchase Warrant X - Other -72,658 0 -100.00

2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock C - Conversion -216,573 0 -100.00

2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock J - Other -1,402 216,573 -0.64 14.00 -19,628 3,032,022

2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock X - Other 217,975 217,975

2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock Purchase Warrant X - Other -217,975 0 -100.00

2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series B Preferred Stock C - Conversion -4,404,887 0 -100.00

2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Series A Preferred Stock C - Conversion -1,415,642 0 -100.00

2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock P - Purchase 510,442 6,619,734 8.36 14.00 7,146,188 92,676,276

2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock C - Conversion 72,190 6,109,292 1.20

2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock C - Conversion 216,573 6,037,102 3.72

2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock C - Conversion 4,404,887 5,820,529 311.16

2014-06-26 2014-06-24 4 ARDX ARDELYX, INC.
Common Stock C - Conversion 1,415,642 1,415,642

2014-06-16 2014-06-12 4 CLVS Clovis Oncology, Inc.
Stock Option (Right to Buy) A - Award -12,414 12,414 -50.00

2014-06-16 2014-06-12 4 FOLD AMICUS THERAPEUTICS INC
Director Stock Option (Right to Buy) A - Award 15,000 15,000

2014-06-09 2014-06-06 4 HPTX HYPERION THERAPEUTICS INC
Common Stock S - Sale -1,134 0 -100.00 26.90 -30,506

2014-06-09 2014-06-06 4 HPTX HYPERION THERAPEUTICS INC
Common Stock S - Sale -148 0 -100.00 26.80 -3,966

2014-06-09 2014-06-06 4 HPTX HYPERION THERAPEUTICS INC
Common Stock S - Sale -148 0 -100.00 26.77 -3,962

2014-06-06 2014-06-05 4 HPTX HYPERION THERAPEUTICS INC
Common Stock J - Other 1,134 1,134

2014-06-06 2014-06-05 4 HPTX HYPERION THERAPEUTICS INC
Common Stock J - Other 148 148

2014-06-06 2014-06-05 4 HPTX HYPERION THERAPEUTICS INC
Common Stock J - Other 148 148

2014-06-06 2014-06-05 4 HPTX HYPERION THERAPEUTICS INC
Common Stock J - Other -5,000 0 -100.00

2014-06-06 2014-06-05 4 HPTX HYPERION THERAPEUTICS INC
Common Stock J - Other 5,000 5,000

2014-06-06 2014-06-05 4 HPTX HYPERION THERAPEUTICS INC
Common Stock J - Other -500,000 2,384,221 -17.34

2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Warrant to Purchase Common Stock (right to buy) C - Conversion 55,831 55,831

2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Warrant to Purchase Series D Preferred Stock (right to buy) C - Conversion -55,831 0 -100.00 15.81 -882,470

2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series E Preferred Stock C - Conversion -411,234 0 -100.00

2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series D Preferred Stock C - Conversion -1,236,487 0 -100.00

2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series C Preferred Stock C - Conversion -531,758 0 -100.00

2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series B Preferred Stock C - Conversion -383,249 0 -100.00

2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Series A Preferred Stock C - Conversion -797,208 0 -100.00

2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock C - Conversion 411,234 3,943,269 11.64

2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock C - Conversion 1,236,487 3,532,035 53.86

2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock C - Conversion 531,758 2,295,548 30.15

2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock C - Conversion 383,249 1,763,790 27.76

2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock C - Conversion 797,208 1,380,541 136.66

2014-04-24 2014-04-22 4 TRIV TriVascular Technologies, Inc.
Common Stock P - Purchase 583,333 583,333 12.00 6,999,996 6,999,996

2014-04-09 2014-04-09 4 OPWR OPOWER, INC.
Series C Preferred Stock C - Conversion -1,123,596 0 -100.00

2014-04-09 2014-04-09 4 OPWR OPOWER, INC.
Series B Preferred Stock C - Conversion -7,866,170 0 -100.00

2014-04-09 2014-04-09 4 OPWR OPOWER, INC.
Common Stock C - Conversion 8,989,766 8,989,766

2014-04-03 2014-04-02 4 HIVE AEROHIVE NETWORKS, INC
Series E Preferred Stock C - Conversion -1,065,143 0 -100.00

2014-04-03 2014-04-02 4 HIVE AEROHIVE NETWORKS, INC
Series D Preferred Stock C - Conversion -3,588,446 0 -100.00

2014-04-03 2014-04-02 4 HIVE AEROHIVE NETWORKS, INC
Common Stock C - Conversion 4,653,589 4,673,589 23,267.94

2014-03-27 3 HIVE AEROHIVE NETWORKS, INC
Common Stock 40,000

2014-03-27 3 HIVE AEROHIVE NETWORKS, INC
Common Stock 40,000

2014-03-13 2014-03-05 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -14,500 0 -100.00 95.34 -1,382,475

2014-03-13 2014-03-05 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -20,500 14,500 -58.57 94.28 -1,932,767 1,367,079

2014-03-11 2014-03-07 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -1,491 35,000 -4.09 93.07 -138,765 3,257,387

2014-03-11 2014-03-07 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -11,433 36,491 -23.86 91.05 -1,041,007 3,322,608

2014-03-11 2014-03-07 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -10,700 47,924 -18.25 90.62 -969,620 4,342,811

2014-03-07 2014-03-06 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -7,702 58,624 -11.61 96.13 -740,368 5,635,332

2014-03-07 2014-03-06 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -22,146 66,326 -25.03 95.42 -2,113,081 6,328,555

2014-03-07 2014-03-06 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -20,152 88,472 -18.55 94.32 -1,900,672 8,344,396

2014-03-07 2014-03-05 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -5,039 0 -100.00 95.50 -481,224

2014-03-07 2014-03-05 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -3,673 0 -100.00 95.50 -350,772

2014-03-07 2014-03-05 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -8,712 0 -100.00 95.50 -831,996

2014-03-07 2014-03-05 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -17,425 0 -100.00 95.50 -1,664,088

2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class B Common Stock C - Conversion -1,607,096 4,821,288 -25.00

2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock J - Other 89,428 108,624 465.87

2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -10,804 19,196 -36.01 97.31 -1,051,373 1,868,026

2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock J - Other 5,039 5,039

2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock J - Other 3,673 3,673

2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock J - Other 8,712 8,712

2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock J - Other 17,425 17,425

2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock J - Other -493,378 0 -100.00

2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock J - Other 493,378 493,378

2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock J - Other -1,607,096 0 -100.00

2014-03-05 2014-03-04 4 DATA Tableau Software Inc
Class A Common Stock C - Conversion 1,607,096 1,607,096

2014-03-05 2014-03-03 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -10,000 30,000 -25.00 96.00 -960,012 2,880,036

2014-03-05 2014-03-03 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -20,000 40,000 -33.33 95.14 -1,902,702 3,805,404

2014-02-28 2014-02-27 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -6,516 60,000 -9.80 97.11 -632,769 5,826,600

2014-02-28 2014-02-27 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -14,874 66,516 -18.27 96.70 -1,438,316 6,432,097

2014-02-28 2014-02-27 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -16,547 81,390 -16.90 95.54 -1,580,900 7,776,001

2014-02-28 2014-02-27 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -80,819 97,937 -45.21 94.47 -7,634,971 9,252,108

2014-02-28 2014-02-27 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -10,078 0 -100.00 95.35 -960,937

2014-02-28 2014-02-27 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -7,346 0 -100.00 95.45 -701,180

2014-02-28 2014-02-27 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -17,424 0 -100.00 95.27 -1,659,972

2014-02-28 2014-02-27 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -34,848 0 -100.00 94.90 -3,307,009

2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class B Common Stock C - Conversion -3,214,192 6,428,384 -33.33

2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock J - Other 178,756 178,756

2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock J - Other 10,078 10,078

2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock J - Other 7,346 7,346

2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock J - Other 17,424 17,424

2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock J - Other 34,848 34,848

2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock J - Other -986,757 0 -100.00

2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock J - Other 986,757 986,757

2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock J - Other -3,214,192 0 -100.00

2014-02-28 2014-02-26 4 DATA Tableau Software Inc
Class A Common Stock C - Conversion 3,214,192 3,214,192

2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series C Preferred Stock C - Conversion -4,840,686 0 -100.00

2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series B-1 Preferred Stock C - Conversion -1,462,857 0 -100.00

2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series B-1 Preferred Stock S - Sale -487,143 1,462,857 -24.98 1.13 -549,984 1,651,566

2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series B-1 Preferred Stock X - Other 550,000 1,950,000 39.29 1.00 550,000 1,950,000

2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series B-1 Warrants X - Other -550,000 0 -100.00

2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series B Preferred Stock C - Conversion -8,400,000 0 -100.00

2014-02-07 2014-02-05 4 TRVN TREVENA INC
Series A Preferred Stock C - Conversion -6,000,000 0 -100.00

2014-02-07 2014-02-05 4 TRVN TREVENA INC
Common Stock P - Purchase 472,410 3,811,691 14.15 7.00 3,306,870 26,681,837

2014-02-07 2014-02-05 4 TRVN TREVENA INC
Common Stock C - Conversion 3,339,281 3,339,281

2014-01-29 2014-01-29 4 CRCM Care.com Inc
Series E Convertible Preferred Stock C - Conversion -612,089 0 -100.00

2014-01-29 2014-01-29 4 CRCM Care.com Inc
Series D Convertible Preferred Stock C - Conversion -401,837 0 -100.00

2014-01-29 2014-01-29 4 CRCM Care.com Inc
Series C Convertible Preferred Stock C - Conversion -2,242,087 0 -100.00

2014-01-29 2014-01-29 4 CRCM Care.com Inc
Common Stock C - Conversion 612,089 3,256,013 23.15

2014-01-29 2014-01-29 4 CRCM Care.com Inc
Common Stock C - Conversion 401,837 2,643,924 17.92

2014-01-29 2014-01-29 4 CRCM Care.com Inc
Common Stock C - Conversion 2,242,087 2,242,087

2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock Warrant (right to buy) X - Other -56,983 0 -100.00

2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock Warrant (right to buy) X - Other -160,672 0 -100.00

2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock Warrant (right to buy) X - Other -749,721 0 -100.00

2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock D - Sale to Issuer -13,551 2,316,692 -0.58 10.96 -148,519 25,390,944

2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock X - Other 56,983 2,330,243 2.51 10.96 624,534 25,539,463

2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock D - Sale to Issuer -38,210 2,273,260 -1.65 10.96 -418,782 24,914,930

2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock X - Other 160,672 2,311,470 7.47 10.96 1,760,965 25,333,711

2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock D - Sale to Issuer -260,280 2,150,798 -10.80 16.00 -4,164,480 34,412,768

2014-01-28 2014-01-27 4 ECOM CHANNELADVISOR CORP
Common Stock X - Other 749,721 2,411,078 45.13 16.00 11,995,536 38,577,248

2014-01-23 2014-01-21 4 SUPN SUPERNUS PHARMACEUTICALS INC
Director Stock Option (Right to Buy) A - Award 7,457 7,457

2014-01-23 2014-01-21 4 CVT CVENT INC
Common Stock S - Sale -169,887 5,994,106 -2.76 35.50 -6,030,988 212,790,763

2014-01-21 2014-01-16 4 CVT CVENT INC
Common Stock S - Sale -1,132,589 6,163,993 -15.52 35.50 -40,206,910 218,821,752

2014-01-15 2014-01-15 4 GLYC GLYCOMIMETICS INC
Series A-1 Preferred Stock C - Conversion -11,824,058 0 -100.00

2014-01-15 2014-01-15 4 GLYC GLYCOMIMETICS INC
Series A-1 Preferred Stock C - Conversion -11,250,850 0 -100.00

2014-01-15 2014-01-15 4 GLYC GLYCOMIMETICS INC
Common Stock P - Purchase 512,500 4,093,377 14.31 8.00 4,100,000 32,747,016

2014-01-15 2014-01-15 4 GLYC GLYCOMIMETICS INC
Common Stock C - Conversion 3,580,877 3,580,877

2014-01-15 2014-01-15 4 GLYC GLYCOMIMETICS INC
Common Stock P - Purchase 487,500 4,481,758 12.21 8.00 3,900,000 35,854,064

2014-01-15 2014-01-15 4 GLYC GLYCOMIMETICS INC
Common Stock C - Conversion 3,407,283 3,994,258 580.48

2014-01-13 2014-01-09 4 GLYC GLYCOMIMETICS INC
Stock Option (right to buy) A - Award 15,401 15,401

2014-01-09 3 GLYC GLYCOMIMETICS INC
Common Stock 586,975

2013-12-12 2013-12-11 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -562 0 -100.00 6.22 -3,496

2013-12-12 2013-12-11 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -1,452 0 -100.00 6.22 -9,031

2013-12-12 2013-12-10 4 WIFI BOINGO WIRELESS INC
Common Stock J - Other 562 562

2013-12-12 2013-12-10 4 WIFI BOINGO WIRELESS INC
Common Stock J - Other 1,452 1,452

2013-12-12 2013-12-10 4 WIFI BOINGO WIRELESS INC
Common Stock J - Other -10,000 0 -100.00

2013-12-12 2013-12-10 4 WIFI BOINGO WIRELESS INC
Common Stock J - Other 10,000 10,000

2013-12-12 2013-12-10 4 WIFI BOINGO WIRELESS INC
Common Stock J - Other -1,000,000 4,467,960 -18.29

2013-12-05 2013-12-05 4 TRGT TARGACEPT INC
Common Stock S - Sale -1,000 0 -100.00 5.13 -5,131

2013-12-05 2013-12-03 4 TRGT TARGACEPT INC
Director Stock Option (right to buy) M - Exercise -7,500 0 -100.00

2013-12-05 2013-12-03 4 TRGT TARGACEPT INC
Director Stock Option (right to buy) M - Exercise -7,500 0 -100.00

2013-12-05 2013-12-03 4 TRGT TARGACEPT INC
Common Stock S - Sale -15,000 0 -100.00 5.38 -80,754

2013-12-05 2013-12-03 4 TRGT TARGACEPT INC
Common Stock M - Exercise 7,500 15,000 100.00 4.16 31,200 62,400

2013-12-05 2013-12-03 4 TRGT TARGACEPT INC
Common Stock M - Exercise 7,500 7,500 2.71 20,325 20,325

2013-11-22 2013-11-21 4 TRGT TARGACEPT INC
Common Stock S - Sale -5,333 1,000 -84.21 5.16 -27,533 5,163

2013-11-20 2013-11-20 4 DATA Tableau Software Inc
Class B Common Stock C - Conversion -1,152,625 9,642,576 -10.68

2013-11-20 2013-11-20 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -1,152,625 0 -100.00 62.72 -72,298,403

2013-11-20 2013-11-20 4 DATA Tableau Software Inc
Class A Common Stock C - Conversion 1,152,625 1,152,625

2013-11-18 2013-11-15 4 EPZM Epizyme, Inc.
Common Stock P - Purchase 25,800 406,500 6.78 19.31 498,185 7,849,312

2013-11-18 2013-11-15 4 EPZM Epizyme, Inc.
Common Stock P - Purchase 23,700 380,700 6.64 20.31 481,269 7,730,761

2013-11-18 2013-11-14 4 EPZM Epizyme, Inc.
Common Stock P - Purchase 163,620 357,000 84.61 19.04 3,115,538 6,797,744

2013-11-18 2013-11-14 4 EPZM Epizyme, Inc.
Common Stock P - Purchase 152,459 193,380 372.57 19.99 3,047,335 3,865,260

2013-11-18 2013-11-14 4 EPZM Epizyme, Inc.
Common Stock P - Purchase 40,921 40,921 20.91 855,654 855,654

2013-11-14 2013-11-13 4 DATA Tableau Software Inc
Class B Common Stock C - Conversion -6,756,077 10,795,201 -38.49

2013-11-14 2013-11-13 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -6,756,077 0 -100.00 62.72 -423,774,930

2013-11-14 2013-11-13 4 DATA Tableau Software Inc
Class A Common Stock C - Conversion 6,756,077 6,756,077

2013-11-13 2013-11-12 4 ECOM CHANNELADVISOR CORP
Common Stock S - Sale -201,012 1,661,357 -10.79 32.37 -6,506,758 53,778,126

2013-11-13 2013-11-12 4 ECOM CHANNELADVISOR CORP
Common Stock S - Sale -903,229 1,862,369 -32.66 32.37 -29,237,523 60,284,885

2013-11-06 2013-11-05 4 ADNC AUDIENCE INC
Common Stock S - Sale -2,573 0 -100.00 9.83 -25,288

2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock J - Other 508 508

2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock J - Other 254 254

2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock J - Other 107 107

2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock J - Other 147 147

2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock J - Other 2,573 2,573

2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock J - Other -14,390 0 -100.00

2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock J - Other 14,390 14,390

2013-11-06 2013-11-04 4 ADNC AUDIENCE INC
Common Stock J - Other -1,439,003 1,439,002 -50.00

2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock J - Other 162 952 20.51

2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock J - Other 790 790

2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock J - Other 3,994 3,994

2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock J - Other 167 167

2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock J - Other 229 229

2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock J - Other 395 395

2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock J - Other -22,394 0 -100.00

2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock J - Other 22,394 22,394

2013-10-31 2013-10-29 4 XOOM XOOM Corp
Common Stock J - Other -2,239,385 2,239,385 -50.00

2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock J - Other 41,260 41,260

2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock J - Other 5,918 5,918

2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock J - Other 5,918 5,918

2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock J - Other -200,000 0 -100.00

2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock J - Other 200,000 200,000

2013-09-17 2013-09-13 4 GRPN Groupon, Inc.
Class A Common Stock J - Other -20,000,000 54,184,956 -26.96

2013-09-13 2013-06-04 4/A CLVS Clovis Oncology, Inc.
Common Stock S - Sale -2,483 0 -100.00 70.80 -175,796

2013-09-13 2013-06-03 4/A CLVS Clovis Oncology, Inc.
Common Stock J - Other 287 287

2013-09-13 2013-06-03 4/A CLVS Clovis Oncology, Inc.
Common Stock J - Other 2,483 2,483

2013-09-13 2013-06-03 4/A CLVS Clovis Oncology, Inc.
Common Stock J - Other 287 287

2013-09-13 2013-06-03 4/A CLVS Clovis Oncology, Inc.
Common Stock J - Other -11,399 0 -100.00

2013-09-13 2013-06-03 4/A CLVS Clovis Oncology, Inc.
Common Stock J - Other 11,399 11,399

2013-09-13 2013-06-03 4/A CLVS Clovis Oncology, Inc.
Common Stock J - Other -1,139,890 2,279,781 -33.33

2013-08-23 2013-08-22 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -543 0 -100.00 7.23 -3,926

2013-08-23 2013-08-22 4 WIFI BOINGO WIRELESS INC
Common Stock S - Sale -1,414 0 -100.00 7.16 -10,121

2013-08-23 2013-08-21 4 WIFI BOINGO WIRELESS INC
Common Stock J - Other 543 543

2013-08-23 2013-08-21 4 WIFI BOINGO WIRELESS INC
Common Stock J - Other 1,414 1,414

2013-08-23 2013-08-21 4 WIFI BOINGO WIRELESS INC
Common Stock J - Other -9,650 0 -100.00

2013-08-23 2013-08-21 4 WIFI BOINGO WIRELESS INC
Common Stock J - Other 9,650 9,650

2013-08-23 2013-08-21 4 WIFI BOINGO WIRELESS INC
Common Stock J - Other -965,000 5,467,960 -15.00

2013-08-16 2013-08-15 4 GRPN Groupon, Inc.
Class A Common Stock S - Sale -27,595 0 -100.00 9.77 -269,628

2013-08-16 2013-08-15 4 GRPN Groupon, Inc.
Class A Common Stock S - Sale -3,846 0 -100.00 9.77 -37,575

2013-08-16 2013-08-14 4 GRPN Groupon, Inc.
Class A Common Stock J - Other 27,595 27,595

2013-08-16 2013-08-14 4 GRPN Groupon, Inc.
Class A Common Stock J - Other 3,846 3,846

2013-08-16 2013-08-14 4 GRPN Groupon, Inc.
Class A Common Stock J - Other -130,000 0 -100.00

2013-08-16 2013-08-14 4 GRPN Groupon, Inc.
Class A Common Stock J - Other 130,000 130,000

2013-08-16 2013-08-14 4 GRPN Groupon, Inc.
Class A Common Stock J - Other -13,000,000 74,184,956 -14.91

2013-08-14 2013-08-14 4 CVT CVENT INC
Series A Preferred Stock C - Conversion -7,296,582 0 -100.00

2013-08-14 2013-08-14 4 CVT CVENT INC
Common Stock C - Conversion 7,296,582 7,296,582

2013-07-18 2013-07-18 4 OMTH Omthera Pharmaceuticals, Inc.
Common Stock D - Sale to Issuer -5,833,213 0 -100.00

2013-06-17 2013-06-13 4 CLVS Clovis Oncology, Inc.
Stock Option (Right to Buy) A - Award -12,414 12,414 -50.00

2013-06-17 2013-06-13 4 FOLD AMICUS THERAPEUTICS INC
Director Stock Option (Right to Buy) A - Award 15,000 15,000

2013-06-11 2013-06-10 4 TSRO TESARO, Inc.
Common Stock S - Sale -415 0 -100.00 40.49 -16,803

2013-06-07 2013-06-05 4 EPZM Epizyme, Inc.
Series B Preferred Stock C - Conversion -16,899,721 0 -100.00

2013-06-07 2013-06-05 4 EPZM Epizyme, Inc.
Common Stock P - Purchase 400,000 6,033,240 7.10 15.00 6,000,000 90,498,600

2013-06-07 2013-06-05 4 EPZM Epizyme, Inc.
Common Stock C - Conversion 5,633,240 5,633,240

2013-06-05 2013-06-05 4 TSRO TESARO, Inc.
Common Stock S - Sale -3,583 0 -100.00 39.00 -139,726

2013-06-05 2013-06-04 4 TSRO TESARO, Inc.
Common Stock J - Other 3,583 3,583

2013-06-05 2013-06-04 4 TSRO TESARO, Inc.
Common Stock J - Other 415 415

2013-06-05 2013-06-04 4 TSRO TESARO, Inc.
Common Stock J - Other -16,450 0 -100.00

2013-06-05 2013-06-04 4 TSRO TESARO, Inc.
Common Stock J - Other 16,450 16,450

2013-06-05 2013-06-04 4 TSRO TESARO, Inc.
Common Stock J - Other -1,645,000 9,854,255 -14.31

2013-06-05 2013-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock S - Sale -2,483 0 -100.00 70.80 -175,796

2013-06-05 2013-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock J - Other 2,483 2,483

2013-06-05 2013-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock J - Other 287 287

2013-06-05 2013-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock J - Other -11,399 0 -100.00

2013-06-05 2013-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock J - Other 11,399 11,399

2013-06-05 2013-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock J - Other -1,139,890 2,279,781 -33.33

2013-06-04 2013-06-03 4 TRGT TARGACEPT INC
Stock Option (Right to Buy) X - Other -1,000 0 -100.00

2013-06-04 2013-06-03 4 TRGT TARGACEPT INC
Common Stock X - Other 1,000 6,333 18.75 0.08 75 475

2013-05-29 2013-05-29 4 ECOM CHANNELADVISOR CORP
Series C Preferred Stock C - Conversion -44,249,588 0 -100.00

2013-05-29 2013-05-29 4 ECOM CHANNELADVISOR CORP
Series C Preferred Stock S - Sale -95,980 44,249,588 -0.22 0.88 -83,982 38,718,390

2013-05-29 2013-05-29 4 ECOM CHANNELADVISOR CORP
Series C Preferred Stock X - Other 122,602 44,345,568 0.28 0.68 83,982 30,376,714

2013-05-29 2013-05-29 4 ECOM CHANNELADVISOR CORP
Warrant to Purchase Series C Preferred Stock (right to buy) X - Other -122,602 0 -100.00

2013-05-29 2013-05-29 4 ECOM CHANNELADVISOR CORP
Common Stock C - Conversion 2,765,599 2,765,599

2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Class B Common Stock C - Conversion -2,000,000 17,551,278 -10.23

2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Class B Common Stock C - Conversion 6,541,485 19,551,278 50.28

2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Series B Common Stock C - Conversion -6,541,485 0 -100.00

2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Class B Common Stock C - Conversion 10,602,127 13,009,793 440.35

2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Series A Preferred Stock C - Conversion -10,602,127 0 -100.00

2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Class A Common Stock S - Sale -2,000,000 0 -100.00 28.83 -57,660,000

2013-05-23 2013-05-22 4 DATA Tableau Software Inc
Class A Common Stock C - Conversion 2,000,000 2,000,000

2013-05-23 3 ILIU INTERLEUKIN GENETICS INC
Common Stock 15,429,122

2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Series B Preferred Stock C - Conversion -6,165,747 0 -100.00

2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Secured Convertible Promissory Note C - Conversion -633,219 0 -100.00

2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Warrant (right to buy) C - Conversion -156,250 0 -100.00

2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Common Stock P - Purchase 625,000 5,833,213 12.00 8.00 5,000,000 46,665,704

2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Common Stock C - Conversion 4,418,940 5,208,213 559.87

2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Common Stock C - Conversion 633,219 789,273 405.77 8.00 5,065,752 6,314,184

2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Common Stock S - Sale -196 156,054 -0.13 8.00 -1,568 1,248,432

2013-04-17 2013-04-16 4 OMTH Omthera Pharmaceuticals, Inc.
Common Stock C - Conversion 156,250 156,250 0.01 1,562 1,562

2013-04-11 2013-04-11 4 OMTH Omthera Pharmaceuticals, Inc.
Secured Convertible Promissory Note A - Award 633,219 633,219

2013-04-11 2013-04-11 4 OMTH Omthera Pharmaceuticals, Inc.
Warrant (right to buy) A - Award 156,250 156,250

2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class B Common Stock C - Conversion -2,321,212 4,642,425 -33.33

2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock J - Other 5,344 10,396 105.78

2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock J - Other 687 1,273 117.24

2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock J - Other 687 1,273 117.24

2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock J - Other -23,212 0 -100.00

2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock J - Other 23,212 23,212

2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock J - Other -2,321,212 0 -100.00

2013-04-11 2013-04-10 4 WDAY Workday, Inc.
Class A Common Stock C - Conversion 2,321,212 2,321,212

2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class B Common Stock C - Conversion -2,321,212 4,642,425 -33.33

2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock J - Other 5,052 5,052

2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock J - Other 586 586

2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock J - Other 586 586

2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock J - Other -23,212 0 -100.00

2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock J - Other 23,212 23,212

2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock J - Other -2,321,212 0 -100.00

2013-04-11 2013-04-09 4 WDAY Workday, Inc.
Class A Common Stock C - Conversion 2,321,312 2,321,212 -2,321,312.00

2013-03-08 2013-03-08 4 ADNC AUDIENCE INC
Common Stock S - Sale -510 0 -100.00 12.97 -6,615

2013-03-08 2013-03-08 4 ADNC AUDIENCE INC
Common Stock S - Sale -148 0 -100.00 12.97 -1,920

2013-03-08 2013-03-07 4 ADNC AUDIENCE INC
Common Stock S - Sale -2,792 0 -100.00 12.96 -36,187

2013-02-25 2013-02-21 4 XOOM XOOM Corp
Series F Convertible Preferred Stock C - Conversion -189,966 0 -100.00

2013-02-25 2013-02-21 4 XOOM XOOM Corp
Series E Convertible Preferred Stock C - Conversion -681,458 0 -100.00

2013-02-25 2013-02-21 4 XOOM XOOM Corp
Series D Convertible Preferred Stock C - Conversion -848,420 0 -100.00

2013-02-25 2013-02-21 4 XOOM XOOM Corp
Series C-1 Convertible Preferred Stock C - Conversion -502,386 0 -100.00

2013-02-25 2013-02-21 4 XOOM XOOM Corp
Series C Convertible Preferred Stock C - Conversion -2,256,540 0 -100.00

2013-02-25 2013-02-21 4 XOOM XOOM Corp
Common Stock C - Conversion 4,478,770 4,478,770

2013-02-20 2013-02-15 4 ADNC AUDIENCE INC
Common Stock J - Other 510 510

2013-02-20 2013-02-15 4 ADNC AUDIENCE INC
Common Stock J - Other 148 148

2013-02-20 2013-02-15 4 ADNC AUDIENCE INC
Common Stock J - Other 2,792 2,792

2013-02-20 2013-02-15 4 ADNC AUDIENCE INC
Common Stock J - Other -14,000 0 -100.00

2013-02-20 2013-02-15 4 ADNC AUDIENCE INC
Common Stock J - Other 14,000 14,000

2013-02-20 2013-02-15 4 ADNC AUDIENCE INC
Common Stock J - Other -1,400,000 2,878,005 -32.73

2013-02-07 2013-02-05 4 SUPN SUPERNUS PHARMACEUTICALS INC
Director Stock Option (Right to Buy) A - Award 8,722 8,722

2012-10-30 2012-10-29 4 MM Millennial Media Inc.
Common Stock S - Sale -1,597,787 8,196,614 -16.31 13.44 -21,478,252 110,182,984

2012-10-18 2012-10-17 4 WDAY Workday, Inc.
Class B Common Stock C - Conversion 6,963,636 13,927,273 100.00

2012-10-18 2012-10-17 4 WDAY Workday, Inc.
Series E Convertible Preferred Stock C - Conversion -6,963,636 0 -100.00

2012-10-18 2012-10-17 4 WDAY Workday, Inc.
Class B Common Stock C - Conversion 6,963,637 6,963,637

2012-10-18 2012-10-17 4 WDAY Workday, Inc.
Series E Convertible Preferred Stock C - Conversion -6,963,637 0 -100.00

2012-09-20 2012-08-23 4 FIO FUSION-IO, INC.
Common Stock G - Gift -2,673 1,333 -66.72

2012-09-06 2012-09-05 4 FIO FUSION-IO, INC.
Common Stock S - Sale -64,634 0 -100.00 27.67 -1,788,494

2012-09-06 2012-09-04 4 FIO FUSION-IO, INC.
Common Stock J - Other 1,333 4,006 49.87

2012-09-06 2012-09-04 4 FIO FUSION-IO, INC.
Common Stock J - Other -45,000 0 -100.00

2012-09-06 2012-09-04 4 FIO FUSION-IO, INC.
Common Stock J - Other 45,000 45,000

2012-09-06 2012-09-04 4 FIO FUSION-IO, INC.
Common Stock J - Other -4,500,000 9,038,379 -33.24

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-1 Preferred Stock C - Conversion -611,185 0 -100.00

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Convertible Promissory Note C - Conversion 0

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Convertible Promissory Note C - Conversion 0

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Convertible Promissory Note C - Conversion 0

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock C - Conversion -2,043 0 -100.00

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock C - Conversion -2,043 0 -100.00

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock J - Other -51,744 2,043 -96.20 10.00 -517,440 20,430

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock J - Other -51,744 2,043 -96.20 10.00 -517,440 20,430

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock X - Other 53,787 53,787

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock X - Other 53,787 53,787

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Preferred Stock Warrant (right to buy) X - Other -53,787 0 -100.00

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Preferred Stock Warrant (right to buy) X - Other -53,787 0 -100.00

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock Warrant (right to buy) X - Other -125,291 0 -100.00

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock C - Conversion -898,808 0 -100.00

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock P - Purchase 500,000 2,884,221 20.97 10.00 5,000,000 28,842,210

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock C - Conversion 177,481 2,384,221 8.04

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock C - Conversion 180,459 2,206,740 8.91

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock C - Conversion 434,096 2,026,281 27.26

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock C - Conversion 2,043 1,592,185 0.13

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock C - Conversion 2,043 1,592,185 0.13

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock J - Other -51,119 1,588,099 -3.12

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock X - Other 125,291 1,639,218 8.28

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock C - Conversion 898,808 1,513,927 146.12

2012-08-02 2012-07-31 4 HPTX HYPERION THERAPEUTICS INC
Common Stock C - Conversion 611,185 615,119 15,535.97

2012-07-25 3 HPTX HYPERION THERAPEUTICS INC
Common Stock 3,934

2012-07-03 2012-07-03 4 TSRO TESARO, Inc.
Series B Preferred Stock C - Conversion -5,253,859 0 -100.00

2012-07-03 2012-07-03 4 TSRO TESARO, Inc.
Series A Preferred Stock C - Conversion -5,134,285 0 -100.00

2012-07-03 2012-07-03 4 TSRO TESARO, Inc.
Common Stock P - Purchase 1,111,111 11,499,255 10.70 13.50 14,999,998 155,239,942

2012-07-03 2012-07-03 4 TSRO TESARO, Inc.
Common Stock C - Conversion 10,388,144 10,388,144

2012-06-18 2012-06-14 4 CLVS Clovis Oncology, Inc.
Stock Option (Right to Buy) A - Award -12,414 12,414 -50.00

2012-06-15 2012-06-13 4 FOLD AMICUS THERAPEUTICS INC
Director Stock Option (Right to Buy) A - Award 15,000 15,000

2012-06-11 2012-06-07 4 TRGT TARGACEPT INC
Director Stock Option (Right to Buy) A - Award 7,500 7,500

2012-05-16 2012-05-15 4 ADNC AUDIENCE INC
Series E Preferred Stock C - Conversion -1,349,396 0 -100.00

2012-05-16 2012-05-15 4 ADNC AUDIENCE INC
Series D Preferred Stock C - Conversion -1,111,435 0 -100.00

2012-05-16 2012-05-15 4 ADNC AUDIENCE INC
Series C Preferred Stock C - Conversion -450,952 0 -100.00

2012-05-16 2012-05-15 4 ADNC AUDIENCE INC
Series B-1 Preferred Stock C - Conversion -230,379 0 -100.00

2012-05-16 2012-05-15 4 ADNC AUDIENCE INC
Series B Preferred Stock C - Conversion -1,135,843 0 -100.00

2012-05-16 2012-05-15 4 ADNC AUDIENCE INC
Common Stock C - Conversion 4,278,005 4,278,005

2012-05-08 2012-05-04 4 SUPN SUPERNUS PHARMACEUTICALS INC
Series A Preferred Stock C - Conversion -24,965,000 0 -100.00

2012-05-08 2012-05-04 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock P - Purchase 4,400,000 10,641,250 70.50 5.00 22,000,000 53,206,250

2012-05-08 2012-05-04 4 SUPN SUPERNUS PHARMACEUTICALS INC
Common Stock C - Conversion 6,241,250 6,241,250

2012-05-01 2012-04-27 4 FIO FUSION-IO, INC.
Common Stock J - Other 2,074 2,673 346.24

2012-05-01 2012-04-27 4 FIO FUSION-IO, INC.
Common Stock J - Other -69,998 0 -100.00

2012-04-04 2012-04-03 4 MM Millennial Media Inc.
Series D Preferred Stock C - Conversion -1,758,302 0 -100.00

2012-04-04 2012-04-03 4 MM Millennial Media Inc.
Series C Preferred Stock C - Conversion -8,036,099 0 -100.00

2012-04-04 2012-04-03 4 MM Millennial Media Inc.
Common Stock C - Conversion 9,794,401 9,794,401

2012-03-30 2012-03-28 4 INWK INNERWORKINGS INC
Common Stock J - Other 5,000 15,000 50.00

2012-03-30 2012-03-28 4 INWK INNERWORKINGS INC
Common Stock J - Other -500,000 4,529,190 -9.94

2012-03-28 2012-03-26 4 INWK INNERWORKINGS INC
Common Stock J - Other 10,000 10,000

2012-03-28 2012-03-26 4 INWK INNERWORKINGS INC
Common Stock J - Other -1,000,000 5,029,190 -16.59

2012-03-16 2012-03-14 4 FIO FUSION-IO, INC.
Common Stock J - Other 10,000 69,998 16.67

2012-03-16 2012-03-14 4 FIO FUSION-IO, INC.
Common Stock J - Other -1,000,000 13,538,379 -6.88

2012-03-13 2012-03-09 4 FIO FUSION-IO, INC.
Common Stock J - Other 9,998 59,998 20.00

2012-03-13 2012-03-09 4 FIO FUSION-IO, INC.
Common Stock J - Other -1,000,000 14,538,379 -6.44

2012-03-09 2012-03-07 4 FOLD AMICUS THERAPEUTICS INC
Common Stock P - Purchase 925,154 4,584,311 25.28 5.70 5,273,378 26,130,573

2012-03-07 2012-03-05 4 FIO FUSION-IO, INC.
Common Stock J - Other 10,000 50,000 25.00

2012-03-07 2012-03-05 4 FIO FUSION-IO, INC.
Common Stock J - Other -1,000,000 15,538,379 -6.05

2012-03-01 2012-02-29 4 ECHO Echo Global Logistics, Inc.
Common Stock S - Sale -119 0 -100.00 18.76 -2,232

2012-03-01 2012-02-28 4 ECHO Echo Global Logistics, Inc.
Common Stock J - Other 119 119

2012-03-01 2012-02-28 4 ECHO Echo Global Logistics, Inc.
Common Stock J - Other -4,000 0 -100.00

2012-03-01 2012-02-28 4 ECHO Echo Global Logistics, Inc.
Common Stock J - Other 4,000 4,000

2012-03-01 2012-02-28 4 ECHO Echo Global Logistics, Inc.
Common Stock J - Other -400,000 2,020,219 -16.53

2012-03-01 2012-02-29 4 INWK INNERWORKINGS INC
Common Stock S - Sale -455,360 6,029,190 -7.02 11.42 -5,199,164 68,839,483

2012-02-29 2012-02-27 4 FIO FUSION-IO, INC.
Common Stock J - Other 10,000 40,000 33.33

2012-02-29 2012-02-27 4 FIO FUSION-IO, INC.
Common Stock J - Other -1,000,000 16,538,379 -5.70

2012-02-28 2012-02-24 4 INWK INNERWORKINGS INC
Common Stock S - Sale -334,457 6,484,550 -4.90 11.40 -3,812,810 73,923,870

2012-02-27 2012-02-24 4 FIO FUSION-IO, INC.
Common Stock J - Other 10,000 30,000 50.00

2012-02-27 2012-02-24 4 FIO FUSION-IO, INC.
Common Stock J - Other -1,000,000 17,538,379 -5.39

2012-02-27 2012-02-23 4 FIO FUSION-IO, INC.
Common Stock J - Other 10,000 20,000 100.00

2012-02-27 2012-02-23 4 FIO FUSION-IO, INC.
Common Stock J - Other -1,000,000 18,538,379 -5.12

2012-02-24 2012-02-23 4 INWK INNERWORKINGS INC
Common Stock S - Sale -54,849 6,819,007 -0.80 11.75 -644,344 80,106,967

2012-02-24 2012-02-22 4 INWK INNERWORKINGS INC
Common Stock S - Sale -253,211 6,873,856 -3.55 11.68 -2,957,808 80,294,887

2012-02-23 2012-02-21 4 FIO FUSION-IO, INC.
Common Stock J - Other 10,000 10,000

2012-02-23 2012-02-21 4 FIO FUSION-IO, INC.
Common Stock J - Other -1,000,000 19,538,379 -4.87

2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock Warrant (Right to Buy) U - Other -791,015 0 -100.00

2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock Warrant (Right to Buy) U - Other -263,671 0 -100.00

2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Stock Option (right to buy) D - Sale to Issuer -20,000 0 -100.00

2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Stock Option (right to buy) D - Sale to Issuer -20,000 0 -100.00

2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Stock Option (right to buy) D - Sale to Issuer -20,000 0 -100.00

2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Stock Option (right to buy) D - Sale to Issuer -20,000 0 -100.00

2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Stock Option (right to buy) D - Sale to Issuer -7,500 0 -100.00

2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Stock Option (right to buy) D - Sale to Issuer -7,500 0 -100.00

2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Stock Option (right to buy) D - Sale to Issuer -7,500 0 -100.00

2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock U - Other -746,596 0 -100.00 26.00 -19,411,496

2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock J - Other 746,596 746,596

2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock U - Other -248,864 0 -100.00 26.00 -6,470,464

2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock J - Other 248,864 248,864

2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock U - Other -78,689 0 -100.00 26.00 -2,045,914

2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock J - Other 78,689 78,689

2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock U - Other -68,492 0 -100.00 26.00 -1,780,792

2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock U - Other -6,898,294 0 -100.00 26.00 -179,355,644

2012-02-15 2012-02-13 4 INHX INHIBITEX, INC.
Common Stock U - Other -1,941,407 0 -100.00 26.00 -50,476,582

2012-02-14 2012-02-10 4 FIO FUSION-IO, INC.
Common Stock J - Other 300 599 100.33

2012-02-14 2012-02-10 4 FIO FUSION-IO, INC.
Common Stock J - Other -10,000 0 -100.00

2012-02-14 2012-02-10 4 FIO FUSION-IO, INC.
Common Stock J - Other 10,000 10,000

2012-02-14 2012-02-10 4 FIO FUSION-IO, INC.
Common Stock J - Other -1,000,000 20,538,379 -4.64

2012-02-09 2012-02-07 4 FIO FUSION-IO, INC.
Common Stock J - Other 299 299

2012-02-09 2012-02-07 4 FIO FUSION-IO, INC.
Common Stock J - Other -10,000 0 -100.00

2012-02-09 2012-02-07 4 FIO FUSION-IO, INC.
Common Stock J - Other 10,000 10,000

2012-02-09 2012-02-07 4 FIO FUSION-IO, INC.
Common Stock J - Other -1,000,000 21,538,379 -4.44

2012-02-06 2012-02-06 4 FIO FUSION-IO, INC.
Common Stock S - Sale -23,083 64,634 -26.32 23.05 -532,063 1,489,814

2012-02-06 2012-02-06 4 FIO FUSION-IO, INC.
Common Stock S - Sale -604 0 -100.00 22.19 -13,403

2012-02-06 2012-02-02 4 FIO FUSION-IO, INC.
Common Stock J - Other 604 604

2012-02-06 2012-02-02 4 FIO FUSION-IO, INC.
Common Stock J - Other -20,000 0 -100.00

2012-02-06 2012-02-02 4 FIO FUSION-IO, INC.
Common Stock J - Other 10,000 20,000 100.00

2012-02-06 2012-02-02 4 FIO FUSION-IO, INC.
Common Stock J - Other -1,000,000 22,538,379 -4.25

2012-02-03 2012-02-01 4 INHX INHIBITEX, INC.
Stock Option (right to buy) A - Award 20,000 20,000

2012-01-20 2012-01-19 4 INHX INHIBITEX, INC.
Stock Option (right to buy) M - Exercise -7,500 0 -100.00

2012-01-20 2012-01-19 4 INHX INHIBITEX, INC.
Common Stock M - Exercise 7,500 68,492 12.30 8.79 65,925 602,045

P

Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif

S

Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif

A

Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)

C

Penukaran derivatif

D

Penjualan atau pemindahan sekuriti kembali kepada syarikat

F

Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat

G

Hadiah sekuriti oleh atau kepada orang dalam

K

Swap ekuiti dan urus niaga lindung nilai yang serupa

M

Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)

V

Transaksi dilaporkan secara sukarela pada Borang 4

J

Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)

Tarikh Dagangan	Simbol Saham	Orang dalam	Saham Dilaporkan	Harga Dilaporkan	Saham Dilaraskan	Harga Dilaraskan	Asas Kos	Hari ke Min	Harga pada Min	Kerugian Maks Dielakkan ($)	Kerugian Maks Dielakkan (%)
2014-12-26	ARDX	BARRETT M JAMES	296	21.5449	296	21.5449	6,377	131	8.32	-3,914	-61.38
2014-12-26	ARDX	BARRETT M JAMES	296	21.5449	296	21.5449	6,377
2014-12-26	ARDX	BARRETT M JAMES	1,972	21.2784	1,972	21.2784	41,961

Tarikh Dagangan	Simbol Saham	Orang dalam	Saham Dilaporkan	Harga Dilaporkan	Saham Dilaraskan	Harga Dilaraskan	Asas Kos	Hari ke Min	Harga pada Min	Kerugian Maks Dielakkan ($)	Kerugian Maks Dielakkan (%)
2013-08-15	GRPN	BARRETT M JAMES	3,846	9.7700	192	195.4000	37,575	265	5.3300	-36,552	-97.28
2013-08-15	GRPN	BARRETT M JAMES	27,595	9.7709	1,380	195.4180	269,628

Tarikh Dagangan	Simbol Saham	Orang dalam	Saham Dilaporkan	Harga Dilaporkan	Saham Dilaraskan	Harga Dilaraskan	Asas Kos	Hari ke Min	Harga pada Min	Kerugian Maks Dielakkan ($)	Kerugian Maks Dielakkan (%)
2015-12-08	SUPN	BARRETT M JAMES	70,913	14.7498	70,913	14.7498	1,045,953	58	10.1300	-327,603	-31.32
2015-12-07	SUPN	BARRETT M JAMES	71,067	14.3835	71,067	14.3835	1,022,192
2015-12-04	SUPN	BARRETT M JAMES	70,990	14.5394	70,990	14.5394	1,032,152
2015-11-25	SUPN	BARRETT M JAMES	16,179	16.3480	16,179	16.3480	264,494
2015-11-18	SUPN	BARRETT M JAMES	43,000	16.5010	43,000	16.5010	709,543
2015-11-17	SUPN	BARRETT M JAMES	50,000	16.7092	50,000	16.7092	835,460
2015-11-16	SUPN	BARRETT M JAMES	19,650	16.1341	19,650	16.1341	317,035
2015-11-13	SUPN	BARRETT M JAMES	100,000	16.2561	100,000	16.2561	1,625,610
2015-06-16	SUPN	BARRETT M JAMES	55,105	16.8527	55,105	16.8527	928,668

Tarikh Dagangan	Simbol Saham	Orang dalam	Saham Dilaporkan	Harga Dilaporkan	Saham Dilaraskan	Harga Dilaraskan	Asas Kos	Hari ke Maks	Harga pada Maks	Maks Keuntungan ($)	Pulangan Maks (%)
2014-12-10	TRVN	New Enterprise Associates 12, Limited Partnership	1,000,000	4.0000	40,000	100.0000	4,000,000	282	332.5	9,300,000	232.50
2014-02-05	TRVN	New Enterprise Associates 12, Limited Partnership	472,410	7.0000	18,896	175.0000	3,306,870